0000007084 12/31 2024 Q1 TRUE true xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure utr:bu iso4217:EUR adm:segment 0000007084 2024-01-01 2024-03-31 0000007084 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000007084 us-gaap:DebtSecuritiesMember 2024-01-01 2024-03-31 0000007084 2024-04-29 0000007084 2023-01-01 2023-03-31 0000007084 2024-03-31 0000007084 2023-12-31 0000007084 2022-12-31 0000007084 2023-03-31 0000007084 us-gaap:CommonStockMember 2023-12-31 0000007084 us-gaap:RetainedEarningsMember 2023-12-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000007084 us-gaap:NoncontrollingInterestMember 2023-12-31 0000007084 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000007084 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000007084 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000007084 us-gaap:CommonStockMember 2024-03-31 0000007084 us-gaap:RetainedEarningsMember 2024-03-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000007084 us-gaap:NoncontrollingInterestMember 2024-03-31 0000007084 us-gaap:CommonStockMember 2022-12-31 0000007084 us-gaap:RetainedEarningsMember 2022-12-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000007084 us-gaap:NoncontrollingInterestMember 2022-12-31 0000007084 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000007084 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000007084 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000007084 us-gaap:CommonStockMember 2023-03-31 0000007084 us-gaap:RetainedEarningsMember 2023-03-31 0000007084 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000007084 us-gaap:NoncontrollingInterestMember 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember adm:AgServicesMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember adm:AgServicesMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AgServicesMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:CrushingMember 2024-01-01 2024-03-31 0000007084 adm:CrushingMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:CrushingMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:CrushingMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:RefinedProductsandOtherMember 2024-01-01 2024-03-31 0000007084 adm:RefinedProductsandOtherMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:RefinedProductsandOtherMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:RefinedProductsandOtherMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesandOilseedsMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesandOilseedsMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:StarchesandsweetenersMember 2024-01-01 2024-03-31 0000007084 adm:StarchesandsweetenersMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:StarchesandsweetenersMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:StarchesandsweetenersMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:VCPMember 2024-01-01 2024-03-31 0000007084 adm:VCPMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:VCPMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 adm:CarbohydrateSolutionsMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:CarbohydrateSolutionsMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:HumanNutritionMember 2024-01-01 2024-03-31 0000007084 adm:HumanNutritionMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:HumanNutritionMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AnimalNutritionMember 2024-01-01 2024-03-31 0000007084 adm:AnimalNutritionMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:AnimalNutritionMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 adm:NutritionMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:NutritionMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-03-31 0000007084 us-gaap:AllOtherSegmentsMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 us-gaap:AllOtherSegmentsMember 2024-01-01 2024-03-31 0000007084 us-gaap:TransferredAtPointInTimeMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 us-gaap:TransferredOverTimeMember adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember 2024-01-01 2024-03-31 0000007084 adm:MarktoMarketProductsMember 2024-01-01 2024-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AgServicesMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:CrushingMember 2023-01-01 2023-03-31 0000007084 adm:CrushingMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:CrushingMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:CrushingMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:RefinedProductsandOtherMember 2023-01-01 2023-03-31 0000007084 adm:RefinedProductsandOtherMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:RefinedProductsandOtherMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:RefinedProductsandOtherMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesandOilseedsMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesandOilseedsMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:StarchesandsweetenersMember 2023-01-01 2023-03-31 0000007084 adm:StarchesandsweetenersMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:StarchesandsweetenersMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:StarchesandsweetenersMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:VCPMember 2023-01-01 2023-03-31 0000007084 adm:VCPMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:VCPMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 adm:CarbohydrateSolutionsMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:CarbohydrateSolutionsMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:HumanNutritionMember 2023-01-01 2023-03-31 0000007084 adm:HumanNutritionMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:HumanNutritionMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:AnimalNutritionMember 2023-01-01 2023-03-31 0000007084 adm:AnimalNutritionMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:AnimalNutritionMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 adm:NutritionMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:NutritionMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredOverTimeMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember us-gaap:TransferredAtPointInTimeMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0000007084 us-gaap:AllOtherSegmentsMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0000007084 us-gaap:TransferredAtPointInTimeMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 us-gaap:TransferredOverTimeMember adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:NonMTMProductsandServicesMember 2023-01-01 2023-03-31 0000007084 adm:MarktoMarketProductsMember 2023-01-01 2023-03-31 0000007084 adm:RevelaMember 2024-03-31 0000007084 adm:FDLMember 2024-03-31 0000007084 adm:PTMember 2024-03-31 0000007084 adm:RevelaMember 2024-01-01 2024-03-31 0000007084 adm:FDLMember 2024-01-01 2024-03-31 0000007084 adm:PTMember 2024-01-01 2024-03-31 0000007084 us-gaap:TrademarksAndTradeNamesMember 2024-01-01 2024-03-31 0000007084 us-gaap:TrademarksAndTradeNamesMember adm:RevelaMember 2024-03-31 0000007084 us-gaap:TrademarksAndTradeNamesMember adm:FDLMember 2024-03-31 0000007084 us-gaap:TrademarksAndTradeNamesMember 2024-03-31 0000007084 us-gaap:CustomerListsMember srt:MinimumMember 2024-01-01 2024-03-31 0000007084 us-gaap:CustomerListsMember srt:MaximumMember 2024-01-01 2024-03-31 0000007084 us-gaap:CustomerListsMember adm:RevelaMember 2024-03-31 0000007084 us-gaap:CustomerListsMember adm:FDLMember 2024-03-31 0000007084 us-gaap:CustomerListsMember 2024-03-31 0000007084 adm:RecipesMember srt:MinimumMember 2024-01-01 2024-03-31 0000007084 adm:RecipesMember srt:MaximumMember 2024-01-01 2024-03-31 0000007084 adm:RecipesMember adm:RevelaMember 2024-03-31 0000007084 adm:RecipesMember adm:FDLMember 2024-03-31 0000007084 adm:RecipesMember 2024-03-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2024-03-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2024-03-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel1Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel3Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel1Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel2Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel3Member us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel1Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel2Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:FairValueInputsLevel3Member us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000007084 us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2024-01-01 2024-03-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2024-03-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 us-gaap:LongTermDebtMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 us-gaap:LongTermDebtMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-03-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 us-gaap:LongTermDebtMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 adm:InventoriesCarriedAtMarketMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 adm:InventoryRelatedPayablesMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2024-03-31 0000007084 adm:CommodityDerivativeContractsGainsMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 adm:CommodityDerivativeContractsLossesMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0000007084 us-gaap:NondesignatedMember 2024-03-31 0000007084 us-gaap:NondesignatedMember 2023-12-31 0000007084 us-gaap:SalesMember 2024-01-01 2024-03-31 0000007084 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0000007084 us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-03-31 0000007084 us-gaap:InterestExpenseMember 2024-01-01 2024-03-31 0000007084 us-gaap:SalesMember 2023-01-01 2023-03-31 0000007084 us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0000007084 us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0000007084 us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0000007084 srt:MinimumMember us-gaap:DesignatedAsHedgingInstrumentMember adm:CornMember 2024-03-31 0000007084 srt:MaximumMember us-gaap:DesignatedAsHedgingInstrumentMember adm:CornMember 2024-03-31 0000007084 adm:CornMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000007084 srt:MinimumMember us-gaap:DesignatedAsHedgingInstrumentMember adm:SoybeanMember 2024-03-31 0000007084 srt:MaximumMember us-gaap:DesignatedAsHedgingInstrumentMember adm:SoybeanMember 2024-03-31 0000007084 adm:SoybeanMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000007084 srt:MinimumMember us-gaap:DesignatedAsHedgingInstrumentMember srt:NaturalGasReservesMember 2024-03-31 0000007084 srt:MaximumMember us-gaap:DesignatedAsHedgingInstrumentMember srt:NaturalGasReservesMember 2024-03-31 0000007084 srt:NaturalGasReservesMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000007084 us-gaap:DesignatedAsHedgingInstrumentMember 2024-03-31 0000007084 us-gaap:DesignatedAsHedgingInstrumentMember 2023-12-31 0000007084 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2024-03-31 0000007084 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2023-12-31 0000007084 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember 2023-12-31 0000007084 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember 2024-03-31 0000007084 us-gaap:NetInvestmentHedgingMember 2024-03-31 0000007084 us-gaap:NetInvestmentHedgingMember 2023-12-31 0000007084 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000007084 us-gaap:DesignatedAsHedgingInstrumentMember 2024-01-01 2024-03-31 0000007084 us-gaap:CostOfSalesMember us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000007084 us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0000007084 2023-01-01 2023-12-31 0000007084 us-gaap:LineOfCreditMember 2024-03-31 0000007084 us-gaap:CommercialPaperMember 2024-03-31 0000007084 adm:AccountsReceivableSecuritizationFacilityMember 2024-03-31 0000007084 us-gaap:TaxAndCustomsAdministrationNetherlandsMember 2024-03-31 0000007084 adm:ASR1.0BillionMember 2024-03-31 0000007084 adm:TotalShareRepurchaseProgramMember 2024-03-31 0000007084 adm:TotalShareRepurchaseProgramMember 2024-01-01 2024-03-31 0000007084 adm:ASR1.0BillionMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0000007084 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0000007084 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0000007084 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:OtherNonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000007084 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:AgServicesandOilseedsMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:CarbohydrateSolutionsMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 adm:PreviouslyReportedAfterAdjustmentsMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 adm:RevisionOfPriorPeriodReclassificationAdditionalAdjustmentMember us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 us-gaap:IntersegmentEliminationMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 srt:ScenarioPreviouslyReportedMember us-gaap:OperatingSegmentsMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember us-gaap:OperatingSegmentsMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:NutritionMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember adm:NutritionMember 2023-01-01 2023-03-31 0000007084 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2024-01-01 2024-03-31 0000007084 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0000007084 us-gaap:IntersegmentEliminationMember 2024-01-01 2024-03-31 0000007084 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-03-31 0000007084 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-03-31 0000007084 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-03-31 0000007084 us-gaap:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0000007084 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0000007084 adm:FirstPurchasersMember adm:AccountsReceivableSecuritizationFacilityMember 2024-03-31 0000007084 adm:SecondPurchasersMember adm:AccountsReceivableSecuritizationFacilityMember 2024-03-31 0000007084 us-gaap:AssetPledgedAsCollateralWithoutRightMember 2024-03-31 0000007084 us-gaap:AssetPledgedAsCollateralWithoutRightMember 2023-12-31 0000007084 adm:AOTAndMaizeMember srt:MinimumMember 2024-01-01 2024-03-31 0000007084 adm:AOTAndMaizeMember srt:MaximumMember 2024-01-01 2024-03-31 0000007084 us-gaap:SubsequentEventMember adm:ASR1.0BillionMember 2024-04-15 2024-04-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number 1-44
ARCHER-DANIELS-MIDLAND COMPANY
(Exact name of registrant as specified in its charter)

Delaware |  | 41-0129150
(State or other jurisdiction of incorporation or organization) |  | (I. R. S. Employer Identification No.)
77 West Wacker Drive, Suite 4600 |  |
Chicago, | Illinois |  | 60601
(Address of principal executive offices) |  | (Zip Code)

(312) 634-8100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, no par value | ADM | NYSE
1.000% Notes due 2025 |  | NYSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | ☒ | Accelerated Filer | ☐ | Emerging Growth Company | ☐
Non-accelerated Filer | ☐ | Smaller Reporting Company | ☐ |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Common Stock, no par value – 494,437,789 shares
(April 29, 2024)
SAFE HARBOR STATEMENT
This Quarterly Report on Form 10-Q/A contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this Quarterly Report on Form 10-Q/A, are forward-looking statements. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “outlook,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements the Company makes relating to its future results and operations, growth opportunities, pending litigation and investigations, and timing of the remediation of the Company’s material weakness in the Company’s internal control over financial reporting are forward-looking statements. All forward-looking statements are subject to significant risks, uncertainties and changes in circumstances that could cause actual results and outcomes to differ materially from the forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, without limitation, those that are described in Item 1A, "Risk Factors" included in our Annual Report on Form 10-K/A for the year ended December 31, 2023, as may be updated in this or subsequent Quarterly Reports on Form 10-Q. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Except to the extent required by law, Archer-Daniels- Midland Company does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement whether as a result of new information, future events, changes in assumptions or otherwise.
2

Explanatory Note
Archer-Daniels-Midland Company (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”) to its Quarterly Report on Form 10‑Q for the quarter ended March 31, 2024, which was originally filed with the United States Securities and Exchange Commission (“SEC”) on April 30, 2024 (the “Form 10‑Q”).
In filing this Amendment, the Company is restating its previously issued unaudited consolidated financial statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 (collectively, the “Affected Periods”) for the correction of certain segment-specific historical financial information as further described below.
In addition, the Company filed an amendment to its Annual Report on Form 10-K for the year ended December 31, 2023 and intends to file an amendment to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, originally filed with the SEC on March 12, 2024 and July 30, 2024, respectively (such reports, together with this Amendment, the “Amended Reports”). All material restatement information will be included in the Amended Reports, and the Company does not intend to separately amend other filings that were previously filed with the SEC.
Accordingly, investors and other readers should rely only on the financial information and other disclosures regarding the periods described above in this Amendment and in any other future filings with the SEC (as applicable) and should not rely on any previously issued or filed reports, press releases, corporate presentations or similar communications relating to the Affected Periods.
Background of Correction
Following ongoing dialogue with the staff of the SEC, the Company concluded that it would amend the 2023 Form 10-K and Form 10-Qs for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.
As previously disclosed in Note 13. Segment Information, to the Company’s unaudited Consolidated Financial Statements included in the Form 10-Q, the Company identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, the Company identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the 2023 Form 10-K and Q1 and Q2 2024 Form 10-Qs.
In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, the Company identified additional misclassified intersegment transactions. These newly identified errors concern additional intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment transactions between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. The Company also is correcting certain segment disclosure presentation errors in the Amended Reports.
This Amendment reflects corrections for the newly identified errors related to intersegment sales (described below), the previously-corrected errors related to intersegment sales and segment operating profit, and other segment disclosure corrections (See Note 1 to the Consolidated Financial Statements in this Amendment for further information).
Restatement of Consolidated Financial Statements
This Amendment includes unaudited restated Consolidated Financial Statements for the Affected Periods. See Note 13 to the Consolidated Financial Statements in this Amendment for the restated unaudited segment information as of March 31, 2024 and 2023 for the quarters ended March 31, 2024 and 2023.
3

Items Amended in This Filing
This Amendment amends and restates the following items of the Form 10-Q:
•Part I - Item 1. Financial Statements
•Part I - Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
•Part I - Item 4. Controls and Procedures
•Part II - Item 1A. Risk Factors
•Part II - Item 6. Exhibits
The exhibit list included in Item 6, “Exhibits” herein has been amended to contain currently dated certifications from the Company’s Chief Executive Officer (as Principal Executive Officer) and Chief Financial Officer (as Principal Financial Officer), as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 and filed as Exhibits 31.1/31.2 and 32.1/32.2, respectively.
In accordance with applicable SEC rules, this Form 10-Q/A also includes an updated signature page.
Please note that the only changes to the Form 10-Q are those related to the matters described herein and only in the Items listed above. Otherwise, this Amendment speaks as of the original filing date of the Form 10-Q, and does not modify, amend or update any other item or disclosures in the Form 10-Q. As such, this Amendment does not reflect events occurring after the filing of the Form 10-Q or modify or update those disclosures affected by subsequent events.
Such subsequent information or events include, among others, the information and events described in our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, which we are restating currently with this Amendment, and the information and events described in our Current Reports on Form 8-K filed subsequent to the date of the Form 10-Q. For a description of such subsequent information and events, please read our reports filed pursuant to the Exchange Act subsequent to the date of the Form 10-Q, which update and supersede certain information contained in the Form 10-Q and this Amendment.
4

PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Archer-Daniels-Midland Company
Consolidated Statements of Earnings
(Unaudited)

| Three Months Ended March 31, |  |
| 2024 |  | 2023 |  |  |  |
| (In millions, except per share amounts)
Revenues | $ | 21,847 |  |  | $ | 24,072 |  |  |  |  |
Cost of products sold | 20,188 |  |  | 21,992 |  |  |  |  |
Gross Profit | 1,659 |  |  | 2,080 |  |  |  |  |
Selling, general, and administrative expenses | 951 |  |  | 881 |  |  |  |  |
Asset impairment, exit, and restructuring costs | 18 |  |  | 7 |  |  |  |  |
Equity in earnings of unconsolidated affiliates | (212) |  |  | (174) |  |  |  |  |
Interest and investment income | (123) |  |  | (134) |  |  |  |  |
Interest expense | 166 |  |  | 147 |  |  |  |  |
Other (income) expense – net | (26) |  |  | (44) |  |  |  |  |
Earnings Before Income Taxes | 885 |  |  | 1,397 |  |  |  |  |
Income tax expense | 166 |  |  | 225 |  |  |  |  |
Net Earnings Including Noncontrolling Interests | 719 |  |  | 1,172 |  |  |  |  |
Less: Net earnings (losses) attributable to noncontrolling interests | (10) |  |  | 2 |  |  |  |  |
Net Earnings Attributable to Controlling Interests | $ | 729 |  |  | $ | 1,170 |  |  |  |  |
Average number of shares outstanding – basic | 513 |  |  | 550 |  |  |  |  |
Average number of shares outstanding – diluted | 514 |  |  | 551 |  |  |  |  |
Basic earnings per common share | $ | 1.42 |  |  | $ | 2.13 |  |  |  |  |
Diluted earnings per common share | $ | 1.42 |  |  | $ | 2.12 |  |  |  |  |
Dividends per common share | $ | 0.50 |  |  | $ | 0.45 |  |  |  |  |

See notes to consolidated financial statements.
5

Archer-Daniels-Midland Company
Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)

| Three Months Ended March 31, |  |
| 2024 |  | 2023 |  |  |  |
| (In millions)
Net earnings including noncontrolling interests | $ | 719 |  |  | $ | 1,172 |  |  |  |  |
Other comprehensive income (loss): |  |  |  |  |  |  |
Foreign currency translation adjustment | 4 |  |  | 153 |  |  |  |  |
Tax effect | (20) |  |  | 14 |  |  |  |  |
Net of tax amount | (16) |  |  | 167 |  |  |  |  |
Pension and other postretirement benefit liabilities adjustment | (4) |  |  | (26) |  |  |  |  |
Tax effect | 1 |  |  | (13) |  |  |  |  |
Net of tax amount | (3) |  |  | (39) |  |  |  |  |
Deferred gain (loss) on hedging activities | (69) |  |  | (104) |  |  |  |  |
Tax effect | 10 |  |  | 16 |  |  |  |  |
Net of tax amount | (59) |  |  | (88) |  |  |  |  |
Unrealized gain (loss) on investments | (7) |  |  | 4 |  |  |  |  |
Tax effect | (1) |  |  | (1) |  |  |  |  |
Net of tax amount | (8) |  |  | 3 |  |  |  |  |
Other comprehensive income (loss) | (86) |  |  | 43 |  |  |  |  |
Comprehensive income (loss) | 633 |  |  | 1,215 |  |  |  |  |
Less: Comprehensive income (loss) attributable to noncontrolling interests | (13) |  |  | (1) |  |  |  |  |
Comprehensive income (loss) attributable to controlling interests | $ | 646 |  |  | $ | 1,216 |  |  |  |  |

See notes to consolidated financial statements.
6

Archer-Daniels-Midland Company
Consolidated Balance Sheets

(In millions) | March 31, 2024 |  | December 31, 2023
| (Unaudited) |  |
Assets |  |  |
Current Assets |  |  |
Cash and cash equivalents | $ | 830 |  |  | $ | 1,368 |
Segregated cash and investments | 7,381 |  |  | 7,228 |
Trade receivables - net | 4,178 |  |  | 4,232 |
Inventories | 11,634 |  |  | 11,957 |
Other current assets | 4,983 |  |  | 4,982 |
Total Current Assets | 29,006 |  |  | 29,767 |
Investments and Other Assets |  |  |
Investments in affiliates | 5,566 |  |  | 5,500 |
Goodwill and other intangible assets | 7,051 |  |  | 6,341 |
Right of use assets | 1,285 |  |  | 1,211 |
Other assets | 1,327 |  |  | 1,304 |
Total Investments and Other Assets | 15,229 |  |  | 14,356 |
Property, Plant, and Equipment |  |  |
Land and land improvements | 573 |  |  | 573 |
Buildings | 5,940 |  |  | 5,876 |
Machinery and equipment | 20,298 |  |  | 20,223 |
Construction in progress | 1,421 |  |  | 1,360 |
| 28,232 |  |  | 28,032 |
Accumulated depreciation | (17,636) |  |  | (17,524) |
Net Property, Plant, and Equipment | 10,596 |  |  | 10,508 |
Total Assets | $ | 54,831 |  |  | $ | 54,631 |
Liabilities, Temporary Equity, and Shareholders’ Equity |  |  |
Current Liabilities |  |  |
Short-term debt | $ | 1,734 |  |  | $ | 105 |
Trade payables | 5,599 |  |  | 6,313 |
Payables to brokerage customers | 8,176 |  |  | 7,867 |
Accrued expenses and other payables | 3,922 |  |  | 4,076 |
Current lease liabilities | 298 |  |  | 300 |
Current maturities of long-term debt | 1 |  |  | 1 |
Total Current Liabilities | 19,730 |  |  | 18,662 |
Long-Term Liabilities |  |  |
Long-term debt | 8,245 |  |  | 8,259 |
Deferred income taxes | 1,291 |  |  | 1,309 |
Non-current lease liabilities | 1,010 |  |  | 931 |
Other | 1,016 |  |  | 1,005 |
Total Long-Term Liabilities | 11,562 |  |  | 11,504 |
Temporary Equity - Redeemable noncontrolling interest | 307 |  |  | 320 |
Shareholders’ Equity |  |  |
Common stock | 2,720 |  |  | 3,154 |
Reinvested earnings | 23,069 |  |  | 23,465 |
Accumulated other comprehensive income (loss) | (2,570) |  |  | (2,487) |
Noncontrolling interests | 13 |  |  | 13 |
Total Shareholders’ Equity | 23,232 |  |  | 24,145 |
Total Liabilities, Temporary Equity, and Shareholders’ Equity | $ | 54,831 |  |  | $ | 54,631 |

See notes to consolidated financial statements.
7

Archer-Daniels-Midland Company
Consolidated Statements of Cash Flows
(Unaudited)

(In millions) | Three Months Ended March 31,
| 2024 |  | 2023
Operating Activities |  |  |
Net earnings including noncontrolling interests | $ | 719 |  |  | $ | 1,172 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities |  |  |
Depreciation and amortization | 280 |  |  | 259 |
Asset impairment charges | 3 |  |  | 3 |
Deferred income taxes | (64) |  |  | 47 |
Equity in earnings of affiliates, net of dividends | (136) |  |  | (113) |
Stock compensation expense | 66 |  |  | 65 |
Deferred cash flow hedges | (69) |  |  | (104) |
(Gain) losses on sales/revaluation of assets | 14 |  |  | (11) |
Other – net | 69 |  |  | (8) |
Changes in operating assets and liabilities, net of acquisitions and dispositions |  |  |
Segregated investments | (159) |  |  | (935) |
Trade receivables | 61 |  |  | 488 |
Inventories | 295 |  |  | 52 |
Other current assets | 163 |  |  | 328 |
Trade payables | (713) |  |  | (1,556) |
Payables to brokerage customers | 319 |  |  | (460) |
Accrued expenses and other payables | (148) |  |  | (837) |
Total Operating Activities | 700 |  |  | (1,610) |
Investing Activities |  |  |
Capital expenditures | (328) |  |  | (327) |
Net assets of businesses acquired | (915) |  |  | — |
Proceeds from sales of assets | 6 |  |  | 13 |
Investments in affiliates | (4) |  |  | (4) |
Other – net | 11 |  |  | (10) |
Total Investing Activities | (1,230) |  |  | (328) |
Financing Activities |  |  |
Long-term debt payments | — |  |  | (2) |
Net borrowings (payments) under lines of credit agreements | 1,619 |  |  | 1,306 |
Share repurchases | (1,327) |  |  | (351) |
Cash dividends | (257) |  |  | (248) |
Other – net | (37) |  |  | (107) |
Total Financing Activities | (2) |  |  | 598 |
Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents | (13) |  |  | (6) |
Increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | (545) |  |  | (1,346) |
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period | 5,390 |  |  | 7,033 |
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period | $ | 4,845 |  |  | $ | 5,687 |
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets |  |  |
Cash and cash equivalents | $ | 830 |  |  | $ | 899 |
Restricted cash and restricted cash equivalents included in segregated cash and investments | 4,015 |  |  | 4,788 |
Total cash, cash equivalents, restricted cash, and restricted cash equivalents | $ | 4,845 |  |  | $ | 5,687 |

See notes to consolidated financial statements.
8

Archer-Daniels-Midland-Company
Consolidated Statements of Shareholders’ Equity
(Unaudited)

| Common Stock |  | Reinvested Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Noncontrolling Interests |  | Total Shareholders’ Equity
(In millions, except per share amounts) | Shares |  | Amount |  |  |  |
Balance, December 31, 2023 | 513 |  |  | $ | 3,154 |  |  | $ | 23,465 |  |  | $ | (2,487) |  |  | $ | 13 |  |  | $ | 24,145 |
Comprehensive income |  |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  | 729 |  |  |  |  | (10) |  |  |
Other comprehensive income (loss) |  |  |  |  |  |  | (83) |  |  | (3) |  |  |
Total comprehensive income |  |  |  |  |  |  |  |  |  |  | 633 |
Cash dividends paid - $0.50 per share |  |  |  |  | (257) |  |  |  |  |  |  | (257) |
Share repurchases | (13) |  |  |  |  | (868) |  |  |  |  |  |  | (868) |
Share repurchases prepayment |  |  | (462) |  |  |  |  |  |  |  |  | (462) |
Stock compensation expense | 3 |  |  | 66 |  |  |  |  |  |  |  |  | 66 |
Stock option exercises net of taxes | (1) |  |  | (41) |  |  |  |  |  |  |  |  | (41) |
Other | — |  |  | 3 |  |  | — |  |  | — |  |  | 13 |  |  | 16 |
Balance, March 31, 2024 | 502 |  |  | $ | 2,720 |  |  | $ | 23,069 |  |  | $ | (2,570) |  |  | $ | 13 |  |  | $ | 23,232 |
Balance, December 31, 2022 | 547 |  |  | $ | 3,147 |  |  | $ | 23,646 |  |  | $ | (2,509) |  |  | $ | 33 |  |  | $ | 24,317 |
Comprehensive income |  |  |  |  |  |  |  |  |  |  |
Net earnings |  |  |  |  | 1,170 |  |  |  |  | 2 |  |  |
Other comprehensive income (loss) |  |  |  |  |  |  | 46 |  |  | (3) |  |  |
Total comprehensive income |  |  |  |  |  |  |  |  |  |  | 1,215 |
Cash dividends paid - $0.45 per share |  |  |  |  | (248) |  |  |  |  |  |  | (248) |
Share repurchases | (4) |  |  |  |  | (351) |  |  |  |  |  |  | (351) |
Stock compensation expense | 3 |  |  | 65 |  |  |  |  |  |  |  |  | 65 |
Stock option exercises net of taxes | (1) |  |  | (108) |  |  |  |  |  |  |  |  | (108) |
Other | — |  |  | 2 |  |  | — |  |  | — |  |  | 4 |  |  | 6 |
Balance, March 31, 2023 | 546 |  |  | $ | 3,106 |  |  | $ | 24,217 |  |  | $ | (2,463) |  |  | $ | 36 |  |  | $ | 24,896 |

See notes to consolidated financial statements.
9

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements
(Unaudited)
Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these statements do not include all of the information and footnotes required by GAAP for audited financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. For further information, refer to the consolidated financial statements and notes thereto included in the Annual Report on Form 10-K/A for the year ended December 31, 2023 for Archer-Daniels-Midland Company (the Company or ADM).
Principles of Consolidation
The consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated. The Company consolidates all entities, including variable interest entities (VIEs), in which it has a controlling financial interest. For VIEs, the Company assesses whether it is the primary beneficiary as defined under the applicable accounting standard. Investments in affiliates, including VIEs through which the Company exercises significant influence but does not control the investee and is not the primary beneficiary of the investee’s activities, are carried at cost plus equity in undistributed earnings since acquisition and are adjusted, where appropriate, for basis differences between the investment balance and the underlying net assets of the investee and impairments determined to be other than temporary in nature. The Company’s portion of the results of certain affiliates and results of certain VIEs are included using the most recent available financial statements. In each case, the financial statements are within 93 days of the Company’s year end and are consistent from period to period.
Restatement of Previously Filed Financial Statements
Following ongoing dialogue with the staff of the United States Securities and Exchange Commission, the Company concluded that it would amend its fiscal year 2023 Form 10-K (the “FY2023 Form 10-K”) and Forms 10-Q for the first and second quarters of 2024 (collectively, the “Q1 and Q2 2024 Form 10-Qs”) to restate the segment information disclosure included in those filings. These restatements do not impact ADM’s Consolidated Statements of Earnings, Consolidated Statements of Comprehensive Income (Loss), Consolidated Balance Sheets, Consolidated Statements of Cash Flows or Consolidated Statements of Shareholders’ Equity as of and for the periods presented in the Amended Reports.
As previously disclosed in Note 13. Segment Information, to ADM’s consolidated financial statements included in the Form 10-Q for the quarter ended March 31, 2024, ADM identified and corrected certain intersegment sales amounts that either (i) were not in accordance with prior disclosures about presenting such sales at amounts approximating market or (ii) included intrasegment sales (resulting from sales within the segment) and should have included exclusively intersegment sales (resulting from sales from one segment to another). In connection with the error corrections, ADM identified a material weakness in its internal control over financial reporting related to its accounting practices and procedures for intersegment sales. The Company put in place a plan to remediate this material weakness, as disclosed in the FY2023 Form 10-K and Q1 and Q2 2024 Form 10-Qs.
In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, ADM identified additional intrasegment sales previously misclassified and reported as intersegment sales. These newly identified errors concern intersegment sales for each of its Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments that included certain additional intrasegment sales and should have included exclusively intersegment sales. The Company also identified some intersegment sales between Ag Services and Oilseeds and Carbohydrate Solutions that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales.
The Company also is correcting certain segment disclosure presentation errors. In this Amendment, the Company is revising its reconciliation and calculation of total segment operating profit. The revised reconciliation in Note 13. Segment Information presents a subtotal for total segment operating profit that is equal to the sum of the segment operating profit reported for each of the Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments. Amounts for other business and specified items,
10

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Continued)
which previously were reflected in the calculation of total segment operating profit, are now reflected as reconciling items, similar to Corporate, between total segment operating profit and earnings before income taxes.
The Company has restated its Consolidated Financial Statements for the quarters ended March 31, 2024 and 2023 in Note 13, Segment Information (Unaudited).
Segregated Cash and Investments
The Company segregates certain cash, cash equivalents, and investment balances in accordance with regulatory requirements, commodity exchange requirements, and insurance arrangements. These balances represent deposits received from customers of the Company’s registered futures commission merchant and commodity brokerage services, cash margins and securities pledged to commodity exchange clearinghouses, and cash pledged as security under certain insurance arrangements. Segregated cash and investments also include restricted cash collateral for the various insurance programs of the Company’s captive insurance business. To the degree these segregated balances are comprised of cash and cash equivalents, they are considered restricted cash and cash equivalents on the consolidated statements of cash flows.
Receivables
The Company records receivables at net realizable value in trade receivables, other current assets, and other assets. These amounts include allowances for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances including any accrued interest thereon. The Company estimates uncollectible accounts by pooling receivables according to type, region, credit risk rating, and age. Each pool is assigned an expected loss co-efficient to arrive at a general reserve based on historical write-offs adjusted, as needed, for regional, economic, and other forward-looking factors. The Company minimizes credit risk due to the large and diversified nature of its worldwide customer base. ADM manages its exposure to counter-party credit risk through credit analysis and approvals, credit limits, and monitoring procedures. Long-term receivables recorded in other assets were not material to the Company’s overall receivables portfolio.
Changes to the allowance for estimated uncollectible accounts are as follows:

| March 31, 2024 | March 31, 2023
| (In millions)
Beginning, January 1 | $ | 215 |  | $ | 199 |
Current year provisions | 5 |  | 4
Recoveries | 8 |  | 1 |
Write-offs against allowance | (13) |  | (24) |
Foreign exchange translation adjustment | 1 |  | 1 |
Other | — |  | 1 |
Ending, March 31 | $ | 216 |  | $ | 182 |

Write-offs against allowance in the three months ended March 31, 2024 were primarily related to long-term receivables. Write-offs against allowance in the three months ended March 31, 2023 were primarily related to allowance on receivables that were subsequently sold.
Inventories
Certain merchandisable agricultural commodity inventories, which include inventories acquired under deferred pricing contracts, are stated at market value. In addition, the Company values certain inventories using the first-in, first-out (FIFO) method at the lower of cost or net realizable value.
11

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements (Continued)
The following table sets forth the Company’s inventories as of March 31, 2024 and December 31, 2023.

| March 31, 2024 |  | December 31, 2023
| (In millions)
Raw materials and supplies | $ | 1,880 |  |  | $ | 1,944 |
Finished goods | 3,047 |  |  | 3,026 |
Market inventories | 6,707 |  |  | 6,987 |
Total inventories | $ | 11,634 |  |  | $ | 11,957 |

Included in raw materials and supplies are work in process inventories which were not material as of March 31, 2024 and December 31, 2023.
Cost Method Investments
Cost method investments of $421 million and $438 million as of March 31, 2024 and December 31, 2023, respectively, were included in Other Assets in the Company’s consolidated balance sheets. Revaluation loss of $18 million in the three months ended March 31, 2024 was related to an investment in alternative protein and precision fermentation, partially offset by an upward adjustment of $2 million. There were no revaluation gains or losses in the three months ended March 31, 2023. Revaluation gains and losses are recorded in interest and investment income in the Company’s consolidated statements of earnings. As of March 31, 2024, the cumulative amounts of upward and downward adjustments were $115 million and $94 million, respectively.
Note 2. New Accounting Standards
Through December 31, 2024, the Company has the option to adopt the amended guidance of Accounting Standards Codification (ASC) 848, Reference Rate Reform, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amended guidance do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, except for hedging relationships existing as of December 31, 2024, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. Through March 31, 2024, ADM has completed the transition of its financing, funding, and hedging portfolios from LIBOR to alternative reference rates. The transition did not have an impact on the Company’s consolidated financial statements.
Effective December 31, 2024, the Company will be required to adopt the amended guidance of ASC 280, Segment Reporting, which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for more detailed information about a reportable segment’s expenses. The amended guidance improves reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses and permits entities to disclose more than one measure of a reportable segment’s profitability used by the Chief Operating Decision Maker. The adoption of the amended guidance will result in expanded disclosures in the Company’s segment and geographic information footnote but will not have an impact on the consolidated financial statements.
Effective December 31, 2025, the Company will be required to adopt the amended guidance of ASC 740, Income Taxes, which enhances the transparency and decision usefulness of income tax disclosures. The amendments address investor requests for more transparency about income tax information. The adoption of the amended guidance will result in expanded disclosures in the Company’s income taxes footnote but will not have an impact on the consolidated financial statements.
Note 3. Revenues
Revenue Recognition
The Company principally generates revenue from merchandising and transporting agricultural commodities, and manufacturing products for use in food, beverages, feed, energy, and industrial applications, and ingredients and solutions for human and
12

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 3. Revenues (Continued)
animal nutrition. Revenue is measured based on the consideration specified in the contract with a customer. The Company follows a policy of recognizing revenue at a single point in time when it satisfies its performance obligation by transferring control over a product or service to a customer. The majority of the Company’s contracts with customers have one performance obligation and a contract duration of one year or less. The Company applies the practical expedient in paragraph 10-50-14 of ASC 606, Revenue from Contracts with Customers, (Topic 606) and does not disclose information about remaining performance obligations that have original expected durations of one year or less. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The Company recognized revenue from transportation service contracts of $193 million and $178 million for the three months ended March 31, 2024 and 2023, respectively. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by ASC 610-20, Gains and Losses from the Derecognition of Nonfinancial Assets (Topic 610-20).
Shipping and Handling Costs
Shipping and handling costs related to contracts with customers for the sale of goods are accounted for as a fulfillment activity and are included in cost of products sold. Accordingly, amounts billed to customers for such costs are included as a component of revenues.
Taxes Collected from Customers and Remitted to Governmental Authorities
The Company does not include taxes assessed by governmental authorities that are (i) imposed on and concurrent with a specific revenue-producing transaction and (ii) collected from customers, in the measurement of transaction prices or as a component of revenues and cost of products sold.
Contract Liabilities
Contract liabilities relate to advance payments from customers for goods and services the Company has yet to provide. Contract liabilities of $508 million and $626 million as of March 31, 2024 and December 31, 2023, respectively, were recorded in accrued expenses and other payables in the consolidated balance sheets. Revenues recognized in the three months ended March 31, 2024 from the December 31, 2023 contract liabilities were $235 million.
Disaggregation of Revenues
The following tables present revenue disaggregated by timing of recognition and major product lines for the three months ended March 31, 2024 and 2023.
13

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 3. Revenues (Continued)

| Three Months Ended March 31, 2024
| Topic 606 Revenue | Topic 815(1) | Total
(In millions) | Point in Time | Over Time | Total | Revenue | Revenues
Ag Services and Oilseeds |  |  |  |  |
Ag Services | $ | 1,022 |  | $ | 193 |  | $ | 1,215 |  | $ | 9,982 |  | $ | 11,197 |
Crushing | 117 |  | — |  | 117 |  | 3,210 |  | 3,327 |
Refined Products and Other | 548 |  | — |  | 548 |  | 2,147 |  | 2,695 |
Total Ag Services and Oilseeds | 1,687 |  | 193 |  | 1,880 |  | 15,339 |  | 17,219 |
Carbohydrate Solutions |  |  |  |  |
Starches and Sweeteners | 1,593 |  | — |  | 1,593 |  | 563 |  | 2,156 |
Vantage Corn Processors | 527 |  | — |  | 527 |  | — |  | 527 |
Total Carbohydrate Solutions | 2,120 |  | — |  | 2,120 |  | 563 |  | 2,683 |
Nutrition |  |  |  |  |
Human Nutrition | 964 |  | — |  | 964 |  | — |  | 964 |
Animal Nutrition | 872 |  | — |  | 872 |  | — |  | 872 |
Total Nutrition | 1,836 |  | — |  | 1,836 |  | — |  | 1,836 |
Total Segment Revenues | 5,643 |  | 193 |  | 5,836 |  | 15,902 |  | 21,738 |
Other Business | 109 |  | — |  | 109 |  | — |  | 109 |
Total Revenues | $ | 5,752 |  | $ | 193 |  | $ | 5,945 |  | $ | 15,902 |  | $ | 21,847 |

| Three Months Ended March 31, 2023
| Topic 606 Revenue | Topic 815(1) | Total
(In millions) | Point in Time | Over Time | Total | Revenue | Revenues
Ag Services and Oilseeds |  |  |  |  |
Ag Services | $ | 1,017 |  | $ | 178 |  | $ | 1,195 |  | $ | 10,500 |  | $ | 11,695 |
Crushing | 191 |  | — |  | 191 |  | 3,492 |  | 3,683 |
Refined Products and Other | 626 |  | — |  | 626 |  | 2,575 |  | 3,201 |
Total Ag Services and Oilseeds | 1,834 |  | 178 |  | 2,012 |  | 16,567 |  | 18,579 |
Carbohydrate Solutions |  |  |  |  |
Starches and Sweeteners | 2,084 |  | — |  | 2,084 |  | 653 |  | 2,737 |
Vantage Corn Processors | 800 |  | — |  | 800 |  | — |  | 800 |
Total Carbohydrate Solutions | 2,884 |  | — |  | 2,884 |  | 653 |  | 3,537 |
Nutrition |  |  |  |  |
Human Nutrition | 936 |  | — |  | 936 |  | — |  | 936 |
Animal Nutrition | 917 |  | — |  | 917 |  | — |  | 917 |
Total Nutrition | 1,853 |  | — |  | 1,853 |  | — |  | 1,853 |
Total Segment Revenues | 6,571 |  | 178 |  | 6,749 |  | 17,220 |  | 23,969 |
Other Business | 103 |  | — |  | 103 |  | — |  | 103 |
Total Revenues | $ | 6,674 |  | $ | 178 |  | $ | 6,852 |  | $ | 17,220 |  | $ | 24,072 |

(1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.
14

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 3. Revenues (Continued)
Ag Services and Oilseeds
The Ag Services and Oilseeds segment generates revenue from the sale of commodities, from service fees for the transportation of goods, from the sale of products manufactured in its global processing facilities, and from its structured trade finance activities. Revenue is measured based on the consideration specified in the contract. Revenue is recognized when a performance obligation is satisfied by transferring control over a product or providing service to a customer. For transportation service contracts, the Company recognizes revenue over time as the mode of transportation moves towards its destination in accordance with the transfer of control guidance of Topic 606. The amount of revenue recognized follows the contractually specified price, which may include freight or other contractually specified cost components. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20.
Carbohydrate Solutions
The Carbohydrate Solutions segment generates revenue from the sale of products manufactured at the Company’s global corn and wheat milling facilities around the world. Revenue is recognized when control over products is transferred to the customer. Products are shipped to customers from the Company’s various facilities and from its network of storage terminals. The amount of revenue recognized is based on the consideration specified in the contract, which could include freight and other costs depending on the specific shipping terms of each contract. For physically settled derivative sales contracts that are outside the scope of Topic 606, the Company recognizes revenue when control of the inventory is transferred within the meaning of Topic 606 as required by Topic 610-20.
Nutrition
The Nutrition segment sells ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, edible beans, formula feeds, animal health and nutrition products, pet food and treats, and other specialty food and feed ingredients. Revenue is recognized when control over products is transferred to the customer. The amount of revenue recognized follows the contracted price or the mutually agreed price of the product. Freight and shipping are recognized as a component of revenue at the same time control transfers to the customer.
Other Business
Other Business includes the Company’s futures commission business whose primary sources of revenue are commissions and brokerage income generated from executing orders and clearing futures contracts and options on futures contracts on behalf of its customers. Commissions and brokerage revenue are recognized on the date the transaction is executed. Other Business also includes the Company’s captive insurance business, which generates third party revenue through its proportionate share of premiums from third-party reinsurance pools. Reinsurance premiums are recognized on a straight-line basis over the period underlying the policy.
Note 4. Acquisitions
During the three months ended March 31, 2024, the Company acquired Revela Foods (“Revela”), a Wisconsin-based developer and manufacturer of innovative dairy flavor ingredients and solutions, FDL, a UK-based leading developer and producer of premium flavor and functional ingredient systems, and PT Trouw Nutrition Indonesia (“PT”), a subsidiary of Nutreco and leading provider of functional and nutritional solutions for livestock farming in Indonesia, for an aggregate cash consideration of $924 million.
15

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 4. Acquisitions (Continued)
The aggregate cash consideration of these acquisitions, net of $9 million in cash acquired, was allocated as follows, subject to final measurement period adjustments:

(In millions) | Revela | FDL | PT | Total
Working capital | $ | 50 |  | $ | — |  | $ | 5 |  | $ | 55 |
Property, plant, and equipment | 38 |  | 33 |  | 5 |  | 76 |
Goodwill | 403 |  | 145 |  | 5 |  | 553 |
Other intangible assets | 166 |  | 97 |  | — |  | 263 |
Other long-term assets | 28 |  | 1 |  | — |  | 29 |
Long-term liabilities | (35) |  | (26) |  | — |  | (61) |
Aggregate cash consideration | $ | 650 |  | $ | 250 |  | $ | 15 |  | $ | 915 |

Goodwill recorded in connection with the acquisitions is primarily attributable to the synergies expected to arise after the Company’s acquisition of the businesses. Of the $553 million allocated to goodwill, none is expected to be deductible for tax purposes.
These acquisitions add capabilities to the Human and Animal Nutrition businesses. The Company’s consolidated statement of earnings for the quarter ended March 31, 2024 includes the post-acquisition results of the acquired businesses which were immaterial.
The following table sets forth the fair values and the useful lives of the other intangible assets acquired.

| Useful Lives | Revela | FDL | Total
| (In years) | (In millions)
Intangible assets with finite lives: |  |  |  |  |  |
Trademarks/brands | 3 |  |  | $ | — |  | $ | 4 |  | $ | 4 |
Customer lists | 10 | to | 18 | 124 |  | 73 |  | 197 |
Recipes and others | 10 | to | 21 | 42 |  | 20 |  | 62 |
Total other intangible assets acquired |  |  |  | $ | 166 |  | $ | 97 |  | $ | 263 |

Note 5. Fair Value Measurements
The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2024 and December 31, 2023.
16

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 5. Fair Value Measurements (Continued)

| Fair Value Measurements at March 31, 2024
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
| (In millions)
Assets: |  |  |  |  |  |  |
Inventories carried at market | $ | — |  |  | $ | 3,759 |  |  | $ | 2,948 |  |  | $ | 6,707 |
Unrealized derivative gains: |  |  |  |  |  |  |
Commodity contracts | — |  |  | 598 |  |  | 764 |  |  | 1,362 |
Foreign currency contracts | — |  |  | 187 |  |  | — |  |  | 187 |
Cash equivalents | 206 |  |  | — |  |  | — |  |  | 206 |
Segregated investments | 1,663 |  |  | — |  |  | — |  |  | 1,663 |
Total Assets | $ | 1,869 |  |  | $ | 4,544 |  |  | $ | 3,712 |  |  | $ | 10,125 |
Liabilities: |  |  |  |  |  |  |
Unrealized derivative losses: |  |  |  |  |  |  |
Commodity contracts | $ | — |  |  | $ | 448 |  |  | $ | 435 |  |  | $ | 883 |
Foreign currency contracts | — |  |  | 94 |  |  | — |  |  | 94 |
Inventory-related payables | — |  |  | 1,928 |  |  | 62 |  |  | 1,990 |
Total Liabilities | $ | — |  |  | $ | 2,470 |  |  | $ | 497 |  |  | $ | 2,967 |

| Fair Value Measurements at December 31, 2023
| Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
| (In millions)
Assets: |  |  |  |  |  |  |
Inventories carried at market | $ | — |  |  | $ | 4,274 |  |  | $ | 2,713 |  |  | $ | 6,987 |
Unrealized derivative gains: |  |  |  |  |  |  |
Commodity contracts | — |  |  | 628 |  |  | 731 |  |  | 1,359 |
Foreign currency contracts | — |  |  | 187 |  |  | — |  |  | 187 |
Cash equivalents | 209 |  |  | — |  |  | — |  |  | 209 |
Segregated investments | 1,362 |  |  | — |  |  | — |  |  | 1,362 |
Total Assets | $ | 1,571 |  |  | $ | 5,089 |  |  | $ | 3,444 |  |  | $ | 10,104 |
Liabilities: |  |  |  |  |  |  |
Unrealized derivative losses: |  |  |  |  |  |  |
Commodity contracts | $ | — |  |  | $ | 500 |  |  | $ | 457 |  |  | $ | 957 |
Foreign currency contracts | — |  |  | 144 |  |  | — |  |  | 144 |
Inventory-related payables | — |  |  | 1,219 |  |  | 101 |  |  | 1,320 |
Total Liabilities | $ | — |  |  | $ | 1,863 |  |  | $ | 558 |  |  | $ | 2,421 |

17

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 5. Fair Value Measurements (Continued)
Estimated fair values for inventories and inventory-related payables carried at market are based on exchange-quoted prices, adjusted for differences in local markets and quality, referred to as basis. Market valuations for the Company’s inventories are adjusted for location and quality (basis) because the exchange-quoted prices represent contracts with standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using the inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the inventory is classified in Level 3. Changes in the fair value of inventories and inventory-related payables are recognized in the consolidated statements of earnings as a component of cost of products sold.
Derivative contracts include exchange-traded commodity futures and options contracts, forward commodity purchase and sale contracts, and over-the-counter (OTC) instruments related primarily to agricultural commodities, energy, interest rates, and foreign currencies. Exchange-traded futures and options contracts are valued based on unadjusted quoted prices in active markets and are classified in Level 1. Substantially all of the Company’s exchange-traded futures and options contracts are cash-settled on a daily basis and, therefore, are not included in these tables. Fair value for forward commodity purchase and sale contracts is estimated based on exchange-quoted prices adjusted for differences in local markets. Market valuations for the Company’s forward commodity purchase and sale contracts are adjusted for location (basis) because the exchange-quoted prices represent contracts that have standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using inputs from competitor and broker quotations or market transactions and are considered observable. Basis adjustments are impacted by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these basis adjustments. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When observable inputs are available for substantially the full term of the contract, it is classified in Level 2. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the contract is classified in Level 3. Except for certain derivatives designated as cash flow hedges, changes in the fair value of commodity-related derivatives are recognized in the consolidated statements of earnings as a component of cost of products sold. Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net, depending upon the purpose of the contract. The changes in the fair value of derivatives designated as effective cash flow hedges are recognized in the consolidated balance sheets as a component of accumulated other comprehensive income (AOCI) until the hedged items are recorded in earnings or it is probable the hedged transaction will no longer occur.
The Company’s cash equivalents are comprised of money market funds valued using quoted market prices and are classified as Level 1.
The Company’s segregated investments are comprised of U.S. Treasury securities. U.S. Treasury securities are valued using quoted market prices and are classified in Level 1.
The debt conversion option was the equity linked embedded derivative related to the exchangeable bonds. The fair value of the embedded derivative was included in long-term debt, with changes in fair value recognized as interest, and was valued with the assistance of a third-party pricing service (a level 3 measurement).
18

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 5. Fair Value Measurements (Continued)
The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.

| Level 3 Fair Value Asset Measurements at
| March 31, 2024
| Inventories Carried at Market |  | Commodity Derivative Contracts Gains |  | Total Assets
| (In millions)
Balance, December 31, 2023 | $ | 2,713 |  |  | $ | 731 |  |  | $ | 3,444 |
Total increase (decrease) in net realized/unrealized gains included in cost of products sold* | (97) |  |  | 375 |  |  | 278 |
Purchases | 3,789 |  |  | — |  |  | 3,789 |
Sales | (3,883) |  |  | — |  |  | (3,883) |
Settlements | — |  |  | (352) |  |  | (352) |
Transfers into Level 3 | 516 |  |  | 28 |  |  | 544 |
Transfers out of Level 3 | (90) |  |  | (18) |  |  | (108) |
Ending balance, March 31, 2024 | $ | 2,948 |  |  | $ | 764 |  |  | $ | 3,712 |

* Includes increase in unrealized gains of $564 million relating to Level 3 assets still held at March 31, 2024.
The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2024.

| Level 3 Fair Value Liability Measurements at
| March 31, 2024
| Inventory- related Payables |  | Commodity Derivative Contracts Losses |  |  |  |  |  | Total Liabilities
| (In millions)
Balance, December 31, 2023 | $ | 101 |  |  | $ | 457 |  |  |  |  |  |  | $ | 558 |
Total increase (decrease) in net realized/unrealized losses included in cost of products sold* | (3) |  |  | 329 |  |  |  |  |  |  | 326 |
Purchases | 1 |  |  | — |  |  |  |  |  |  | 1 |
Sales | (38) |  |  | — |  |  |  |  |  |  | (38) |
Settlements | — |  |  | (290) |  |  |  |  |  |  | (290) |
Transfers into Level 3 | 1 |  |  | 13 |  |  |  |  |  |  | 14 |
Transfers out of Level 3 | — |  |  | (74) |  |  |  |  |  |  | (74) |
Ending balance, March 31, 2024 | $ | 62 |  |  | $ | 435 |  |  |  |  |  |  | $ | 497 |

* Includes increase in unrealized losses of $338 million relating to Level 3 liabilities still held at March 31, 2024.
19

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 5. Fair Value Measurements (Continued)
The following table presents a rollforward of assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.

| Level 3 Fair Value Asset Measurements at
| March 31, 2023
| Inventories Carried at Market |  | Commodity Derivative Contracts Gains |  | Total Assets
| (In millions)
Balance, December 31, 2022 | $ | 2,760 |  |  | $ | 541 |  |  | $ | 3,301 |
Total increase (decrease) in net realized/unrealized gains included in cost of products sold* | 2 |  |  | 477 |  |  | 479 |
Purchases | 8,665 |  |  | — |  |  | 8,665 |
Sales | (8,254) |  |  | — |  |  | (8,254) |
Settlements | — |  |  | (382) |  |  | (382) |
Transfers into Level 3 | 605 |  |  | 50 |  |  | 655 |
Transfers out of Level 3 | (275) |  |  | (37) |  |  | (312) |
Ending balance, March 31, 2023 | $ | 3,503 |  |  | $ | 649 |  |  | $ | 4,152 |

* Includes increase in unrealized gains of $632 million relating to Level 3 assets still held at March 31, 2023.
The following table presents a rollforward of liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2023.

| Level 3 Fair Value Liability Measurements at
| March 31, 2023
| Inventory- related Payables |  | Commodity Derivative Contracts Losses |  |  |  | Debt Conversion Option |  | Total Liabilities
| (In millions)
Balance, December 31, 2022 | $ | 89 |  |  | $ | 603 |  |  |  |  | $ | 6 |  |  | $ | 698 |
Total increase (decrease) in net realized/unrealized losses included in cost of products sold and interest expense* | (2) |  |  | 243 |  |  |  |  | (5) |  |  | 236 |
Purchases | 2 |  |  | — |  |  |  |  | — |  |  | 2 |
Settlements | (31) |  |  | (424) |  |  |  |  | — |  |  | (455) |
Transfers into Level 3 | — |  |  | 39 |  |  |  |  | — |  |  | 39 |
Transfers out of Level 3 | (1) |  |  | (6) |  |  |  |  | — |  |  | (7) |
Ending balance, March 31, 2023 | $ | 57 |  |  | $ | 455 |  |  |  |  | $ | 1 |  |  | $ | 513 |

* Includes increase in unrealized losses of $248 million relating to Level 3 liabilities still held at March 31, 2023.
Transfers into Level 3 of assets and liabilities previously classified in Level 2 were due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts rising above the 10% threshold. Transfers out of Level 3 were primarily due to the relative value of unobservable inputs to the total fair value measurement of certain products and derivative contracts falling below the 10% threshold and thus permitting reclassification to Level 2.
In some cases, the price components that result in differences between exchange-traded prices and local prices for inventories
20

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 5. Fair Value Measurements (Continued)
and commodity purchase and sale contracts are observable based upon available quotations for these pricing components, and in some cases, the differences are unobservable. These price components primarily include transportation costs and other adjustments required due to location, quality, or other contract terms. In the table below, these other adjustments are referred to as basis. The changes in unobservable price components are determined by specific local supply and demand characteristics at each facility and the overall market. Factors such as substitute products, weather, fuel costs, contract terms, and futures prices also impact the movement of these unobservable price components.
The following table sets forth the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of March 31, 2024 and December 31, 2023. The Company’s Level 3 measurements may include basis only, transportation cost only, or both price components. As an example, for Level 3 inventories with basis, the unobservable component as of March 31, 2024 is a weighted average 28.2% of the total price for assets and 25.9% of the total price for liabilities.

| Weighted Average % of Total Price
| March 31, 2024 |  | December 31, 2023
Component Type | Assets |  | Liabilities |  | Assets |  | Liabilities
Inventories and Related Payables |  |  |  |  |  |  |
Basis | 28.2 | % |  | 25.9 | % |  | 25.0 | % |  | 33.2 | %
Transportation cost | 18.6 | % |  | — | % |  | 11.5 | % |  | — | %
Commodity Derivative Contracts |  |  |  |  |  |  |
Basis | 40.1 | % |  | 28.2 | % |  | 24.2 | % |  | 24.9 | %
Transportation cost | 8.3 | % |  | 1.5 | % |  | 9.3 | % |  | 3.2 | %

In certain of the Company’s principal markets, the Company relies on price quotes from third parties to value its inventories and physical commodity purchase and sale contracts. These price quotes are generally not further adjusted by the Company in determining the applicable market price. In some cases, availability of third-party quotes is limited to only one or two independent sources. In these situations, absent other corroborating evidence, the Company considers these price quotes as 100% unobservable and, therefore, the fair value of these items is reported in Level 3.
Note 6. Derivative Instruments and Hedging Activities
Derivatives Not Designated as Hedging Instruments
The majority of the Company’s derivative instruments have not been designated as hedging instruments. The Company uses exchange-traded futures and exchange-traded and OTC options contracts to manage its net position of merchandisable agricultural product inventories and forward cash purchase and sales contracts to reduce price risk caused by market fluctuations in agricultural commodities and foreign currencies. The Company also uses exchange-traded futures and exchange-traded and OTC options contracts as components of merchandising strategies designed to enhance margins. The results of these strategies can be significantly impacted by factors such as the correlation between the value of exchange-traded commodities futures contracts and the value of the underlying commodities, counterparty contract defaults, and volatility of freight markets. Derivatives, including exchange-traded contracts and forward commodity purchase or sale contracts, and inventories of certain merchandisable agricultural products, which include amounts acquired under deferred pricing contracts, are stated at fair value. Inventory is not a derivative and therefore fair values of and changes in fair values of inventories are not included in the tables below.
21

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 6. Derivative Instruments and Hedging Activities (Continued)
The following table sets forth the fair value of derivatives not designated as hedging instruments as of March 31, 2024 and December 31, 2023.

| March 31, 2024 |  | December 31, 2023
| Assets |  | Liabilities |  | Assets |  | Liabilities
| (In millions)
Foreign Currency Contracts | $ | 145 |  |  | $ | 94 |  |  | $ | 187 |  |  | $ | 122 |
Commodity Contracts | 1,351 |  |  | 883 |  |  | 1,343 |  |  | 957 |
Total | $ | 1,496 |  |  | $ | 977 |  |  | $ | 1,530 |  |  | $ | 1,079 |

The following tables set forth the pre-tax gains (losses) on derivatives not designated as hedging instruments that have been included in the consolidated statements of earnings for the three months ended March 31, 2024 and 2023.

|  |  |  |  | Other (income) expense - net |  |  |  |
|  |  | Cost of |  |  | Interest |  |
(In millions) | Revenues |  | products sold |  |  | expense |  |
Three Months Ended March 31, 2024 |  |  |  |  |  |  |  |  |
Consolidated Statement of Earnings | $ | 21,847 |  |  | $ | 20,188 |  |  | $ | (26) |  |  | $ | 166 |  |  |
Pre-tax gains (losses) on: |  |  |  |  |  |  |  |  |
Foreign Currency Contracts | $ | 1 |  |  | $ | (63) |  |  | $ | 54 |  |  | $ | — |  |  |
Commodity Contracts | — |  |  | 197 |  |  | — |  |  | — |  |  |
Total gain (loss) recognized in earnings | $ | 1 |  |  | $ | 134 |  |  | $ | 54 |  |  | $ | — |  |  | $ | 189 |
Three Months Ended March 31, 2023 |  |  |  |  |  |  |  |  |
Consolidated Statement of Earnings | $ | 24,072 |  |  | $ | 21,992 |  |  | $ | (44) |  |  | $ | 147 |  |  |
Pre-tax gains (losses) on: |  |  |  |  |  |  |  |  |
Foreign Currency Contracts | $ | (11) |  |  | $ | 95 |  |  | $ | (16) |  |  | $ | — |  |  |
Commodity Contracts | — |  |  | 440 |  |  | — |  |  | — |  |  |
Debt Conversion Option | — |  |  | — |  |  | — |  |  | 5 |  |  |
Total gain (loss) recognized in earnings | $ | (11) |  |  | $ | 535 |  |  | $ | (16) |  |  | $ | 5 |  |  | $ | 513 |

Changes in the market value of inventories of certain merchandisable agricultural commodities, inventory-related payables, forward cash purchase and sales contracts, exchange-traded futures and exchange-traded and OTC options contracts are recognized in earnings immediately as a component of cost of products sold.
Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of earnings as a component of revenues, cost of products sold, and other (income) expense - net depending on the purpose of the contract.
Derivatives Designated as Cash Flow and Net Investment Hedging Strategies
The Company had certain derivatives designated as cash flow and net investment hedges as of March 31, 2024 and December 31, 2023.
22

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 6. Derivative Instruments and Hedging Activities (Continued)
For derivative instruments that are designated and qualify as highly-effective cash flow hedges (i.e., hedging the exposure to variability in expected future cash flow that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of AOCI and as an operating activity in the statement of cash flows, and is reclassified into earnings in the same line item affected by the hedged transaction in the same period or periods during which the hedged transaction affects earnings. Hedge components excluded from the assessment of effectiveness and gains and losses related to discontinued hedges are recognized in the consolidated statement of earnings during the current period.
Commodity Contracts
For each of the hedge programs described below, the derivatives are designated as cash flow hedges. The changes in the market value of such derivative contracts have historically been, and are expected to continue to be, highly effective at offsetting changes in price movements of the hedged item. Once the hedged item is recognized in earnings, the gains and losses arising from the hedge are reclassified from AOCI to either revenues or cost of products sold, as applicable.
The Company uses futures or options contracts to hedge the purchase price of anticipated volumes of corn to be purchased and processed in a future month. The objective of this hedging program is to reduce the variability of cash flows associated with the Company’s forecasted purchases of corn. The Company’s corn processing plants normally grind approximately 59 million bushels of corn per month. During the past 12 months, the Company hedged between 12% and 34% of its monthly grind. At March 31, 2024, the Company had designated hedges representing between 0% and 29% of its anticipated monthly grind of corn for the next 12 months.
The Company uses futures and options contracts to hedge the purchase price of the anticipated volumes of soybeans to be purchased and processed in a future month for certain of its U.S. soybean crush facilities, subject to certain program limits. The Company also uses futures or options contracts to hedge the sales prices of anticipated soybean meal and soybean oil sales proportionate to the soybean crushing process at these facilities, subject to certain program limits. During the past 12 months, the Company hedged between 77% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities. At March 31, 2024, the Company had designated hedges representing between 3% and 100% of the anticipated monthly soybean crush for soybean purchases and soybean meal and oil sales at the designated facilities over the next 12 months.
The Company uses futures and OTC swaps to hedge the purchase price of anticipated volumes of natural gas consumption in a future month for certain of its facilities in North America and Europe, subject to certain program limits. During the past 12 months, the Company hedged between 39% and 80% of the anticipated monthly natural gas consumption at the designated facilities. At March 31, 2024, the Company had designated hedges representing between 34% and 70% of the anticipated monthly natural gas consumption over the next 12 months.
As of March 31, 2024 and December 31, 2023, the Company had after-tax losses of $9 million and after-tax gains of $42 million in AOCI, respectively, related to gains and losses from these programs. The Company expects to recognize $9 million of the March 31, 2024 after-tax losses in its consolidated statement of earnings during the next 12 months.
Foreign Currency Contracts
The Company uses cross-currency swaps and foreign exchange forwards designated as net investment hedges to protect the Company’s investment in a foreign subsidiary against changes in foreign currency exchange rates. The Company executed USD-fixed to Euro-fixed cross-currency swaps with an aggregate notional amount of $0.8 billion as of March 31, 2024 and December 31, 2023, and foreign exchange forwards with an aggregate notional amount of $2.1 billion as of March 31, 2024 and December 31, 2023.
As of March 31, 2024 and December 31, 2023, the Company had after-tax gains of $46 million and after-tax losses of $5 million in AOCI, respectively, related to foreign exchange gains and losses from net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested.
23

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 6. Derivative Instruments and Hedging Activities (Continued)
The following table sets forth the fair value of derivatives designated as hedging instruments as of March 31, 2024 and December 31, 2023.

| March 31, 2024 |  | December 31, 2023
| Assets |  | Liabilities |  | Assets |  | Liabilities
| (In millions)
Commodity Contracts | $ | 11 |  |  | $ | — |  |  | $ | 16 |  |  | $ | — |
Foreign Currency Contracts | 42 |  |  | — |  |  | — |  |  | 22 |
Total | $ | 53 |  |  | $ | — |  |  | $ | 16 |  |  | $ | 22 |

The following table sets forth the pre-tax gains (losses) on derivatives designated as hedging instruments that have been included in the consolidated statements of earnings for the three months ended March 31, 2024 and 2023.

|  |  | Cost of products sold |  |  |  |  |  |  |  |  |  |
(In millions) |  |  |  |  |  |  |  |
Three Months Ended March 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |
Consolidated Statement of Earnings |  |  | $ | 20,188 |  |  |  |  |  |  |  |  |  |  |
Effective amounts recognized in earnings |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-tax gains (losses) on: |  |  |  |  |  |  |  |  |  |  |  |  |
Commodity Contracts |  |  | $ | 19 |  |  |  |  |  |  |  |  |  |  |
Total gain (loss) recognized in earnings |  |  | $ | 19 |  |  |  |  |  |  |  |  |  |  | $ | 19 |
Three Months Ended March 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |
Consolidated Statement of Earnings |  |  | $ | 21,992 |  |  |  |  |  |  |  |  |  |  |
Effective amounts recognized in earnings |  |  |  |  |  |  |  |  |  |  |  |  |
Pre-tax gains (losses) on: |  |  |  |  |  |  |  |  |  |  |  |  |
Commodity Contracts |  |  | $ | (104) |  |  |  |  |  |  |  |  |  |  |
Total gain (loss) recognized in earnings |  |  | $ | (104) |  |  |  |  |  |  |  |  |  |  | $ | (104) |

Other Net Investment Hedging Strategies
The Company has designated €0.7 billion of its outstanding long-term debt and commercial paper borrowings at March 31, 2024 and December 31, 2023 as hedges of its net investment in a foreign subsidiary. As of March 31, 2024 and December 31, 2023, the Company had after-tax gains of $224 million and $212 million in AOCI, respectively, related to foreign exchange gains and losses from the net investment hedge transactions. The amount is deferred in AOCI until the underlying investment is divested.
24

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 7. Other Current Assets
The following table sets forth the items in other current assets:

| March 31, |  | December 31,
| 2024 |  | 2023
| (In millions)
Unrealized gains on derivative contracts | $ | 1,549 |  |  | $ | 1,546 |
Margin deposits and grain accounts | 585 |  |  | 560 |
Customer omnibus receivable | 1,131 |  |  | 1,052 |
Financing receivables - net (1) | 178 |  |  | 237 |
Insurance premiums receivable | 48 |  |  | 61 |
Prepaid expenses | 412 |  |  | 445 |
Biodiesel tax credit | 77 |  |  | 119 |
Tax receivables | 479 |  |  | 491 |
Non-trade receivables | 376 |  |  | 304 |
Other current assets | 148 |  |  | 167 |
| $ | 4,983 |  |  | $ | 4,982 |

(1) The Company provides financing to certain suppliers, primarily Brazilian farmers, to finance a portion of the suppliers’ production costs. The amounts are reported net of allowances of $6 million at March 31, 2024 and December 31, 2023. Interest earned on financing receivables of $5 million and $6 million for the three months ended March 31, 2024 and 2023, respectively, is included in interest and investment income in the consolidated statements of earnings.
Note 8. Accrued Expenses and Other Payables
The following table sets forth the items in accrued expenses and other payables:

| March 31, |  | December 31,
| 2024 |  | 2023
| (In millions)
Unrealized losses on derivative contracts | $ | 977 |  |  | $ | 1,101 |
Accrued compensation | 327 |  |  | 439 |
Income tax payable | 312 |  |  | 284 |
Other taxes payable | 196 |  |  | 172 |
Insurance claims payable | 84 |  |  | 73 |
Contract liability | 508 |  |  | 626 |
Other accruals and payables | 1,518 |  |  | 1,381 |
| $ | 3,922 |  |  | $ | 4,076 |

Note 9. Debt and Financing Arrangements
At March 31, 2024, the fair value of the Company’s long-term debt was below the carrying value by $0.3 billion, as estimated using quoted market prices (a Level 2 measurement under applicable accounting standards).
At March 31, 2024, the Company had lines of credit, including the accounts receivable securitization programs described below, totaling $12.8 billion, of which $8.8 billion was unused. Of the Company’s total lines of credit, $5.0 billion supported
25

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 9. Debt and Financing Arrangements (Continued)
the combined U.S. and European commercial paper borrowing programs, against which there was $0.9 billion of commercial paper outstanding at March 31, 2024.
The Company has accounts receivable securitization programs (the “Programs”). The Programs provide the Company with up to $3.0 billion in funding resulting from the sale of accounts receivable with $0.7 billion unused capacity as of March 31, 2024.
Note 10. Income Taxes
The Company’s effective tax rate was 18.8% for the three months ended March 31, 2024 compared to 16.1% for the three months ended March 31, 2023. The increase in the rate was primarily due to the change in the geographic mix of forecasted pretax earnings and the impact of discrete tax items.
The Organization for Economic Cooperation and Development’s Pillar Two initiative introduced a 15% global minimum tax applied on a country-by-country basis that has been enacted in certain jurisdictions in which the Company operates, with effective dates starting in fiscal year 2024. The Company is in scope of the enacted legislation and has performed an assessment of the potential exposure based on its most recent tax filings, country-by-country reporting, and the financial results of the constituent entities. Based on the assessment, the effective tax rates in most of the jurisdictions in which the Company operates are above the 15% global minimum tax threshold. However, there are a limited number of jurisdictions where the effective tax rate is close to 15%. ADM does not expect a material liability to global minimum tax in those jurisdictions.
The Company is subject to income taxation and routine examinations in many jurisdictions around the world and frequently faces challenges regarding the amount of taxes due. These challenges include positions taken by the Company related to the timing, nature, and amount of deductions and the allocation of income among various tax jurisdictions. In its routine evaluations of the exposure associated with various tax filing positions, the Company recognizes a liability, when necessary, for estimated potential tax owed by the Company in accordance with applicable accounting standards. Resolution of the related tax positions, through negotiations with relevant tax authorities or through litigation, may take years to complete. Therefore, it is difficult to predict the timing for resolution of tax positions and the Company cannot predict or provide assurance as to the ultimate outcome of these ongoing or future examinations. However, the Company does not anticipate the total amount of unrecognized tax benefits will increase or decrease significantly in the next twelve months. Given the long periods of time involved in resolving tax positions, the Company does not expect the recognition of unrecognized tax benefits will have a material impact on the Company’s effective income tax rate in any given period.
In 2014, the Company’s wholly-owned subsidiary in the Netherlands, ADM Europe B.V., received a tax assessment from the Netherlands tax authority challenging the transfer pricing aspects of a 2009 business reorganization, which involved two of its subsidiary companies in the Netherlands. As of March 31, 2024, this assessment was $88 million in tax and $34 million in interest (adjusted for variation in currency exchange rates). On April 23, 2020, the court issued an unfavorable ruling and in October 2020, assigned a third party expert to establish a valuation. During the second quarter of 2021, the third party expert issued a final valuation. On September 30, 2022, the court issued a ruling consistent with the valuation report, and the Dutch tax authorities have filed an appeal. During the quarter ended March 31, 2023, ADM filed a cross-appeal and is currently awaiting the court’s ruling. As of March 31, 2024, the Company has accrued its best estimate of what it believes will be the likely outcome of the litigation.
Note 11. Shareholders’ Equity
Accelerated Share Repurchase
On March 12, 2024, the Company entered into an accelerated share repurchase (“ASR”) transaction agreement (“ASR Agreement”) with Merrill Lynch International, an affiliate of BofA Securities, Inc., to repurchase $1.0 billion (the “Prepayment Amount”) of ADM common stock (“Common Stock”). The ASR transaction is part of ADM’s existing share repurchase program to repurchase up to 200 million shares through December 31, 2024.
Under the terms of the ASR Agreement, on March 13, 2024, the Company paid the Prepayment Amount and received no upfront shares of Common Stock. The total number of shares of Common Stock to be repurchased under the ASR Agreement will be based on volume weighted-average prices of the Common Stock during the term of the ASR transaction less a discount and subject to certain adjustments pursuant to the terms of the ASR Agreement. ADM will receive share deliveries at the end
26

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 11. Shareholders’ Equity (Continued)
of each month commencing in March 2024, and upon final settlement of the ASR transaction, which is expected to occur no later than the end of the second quarter of 2024.
On March 28, 2024, the Company received an interim delivery of 8,880,986 shares at an average share price of $60.596 or $538 million. The Prepayment Amount initially recorded in additional paid in capital was partially reclassified to reinvested earnings for the $538 million amount repurchased.
As of March 31, 2024, the Company had 38.5 million remaining shares under its share repurchase program.
Accumulated Other Comprehensive Income
The following tables set forth the changes in AOCI by component for the three months ended March 31, 2024 and the reclassifications out of AOCI for the three months ended March 31, 2024 and 2023:

| Three months ended March 31, 2024
| Foreign Currency Translation Adjustment |  | Deferred Gain (Loss) on Hedging Activities |  | Pension Liability Adjustment |  | Unrealized Gain (Loss) on Investments |  | Total
| (In millions)
Balance at December 31, 2023 | $ | (2,539) |  |  | $ | 158 |  |  | $ | (108) |  |  | $ | 2 |  |  | $ | (2,487) |
Other comprehensive income (loss) before reclassifications | (77) |  |  | (50) |  |  | (2) |  |  | (7) |  |  | (136) |
Gain (loss) on net investment hedges | 84 |  |  | — |  |  | — |  |  | — |  |  | 84 |
Amounts reclassified from AOCI | — |  |  | (19) |  |  | (2) |  |  | — |  |  | (21) |
Tax effect | (20) |  |  | 10 |  |  | 1 |  |  | (1) |  |  | (10) |
Net of tax amount | (13) |  |  | (59) |  |  | (3) |  |  | (8) |  |  | (83) |
Balance at March 31, 2024 | $ | (2,552) |  |  | $ | 99 |  |  | $ | (111) |  |  | $ | (6) |  |  | $ | (2,570) |

| Amount reclassified from AOCI |
| Three months ended March 31, |  |  | Affected line item in the consolidated statements of earnings
Details about AOCI components | 2024 | 2023 |  |  |
| (In millions) |
Deferred loss (gain) on hedging activities |  |  |  |  |  |
| (19) |  | 104 |  |  |  |  | Cost of products sold
| (19) |  | 104 |  |  |  |  | Total before tax
| 4 |  | (18) |  |  |  |  | Tax
| $ | (15) |  | $ | 86 |  |  |  |  | Net of tax
Pension liability adjustment |  |  |  |  |  |
Amortization of defined benefit pension items: |  |  |  |  |  |
Prior service loss (credit) | $ | (5) |  | $ | (11) |  |  |  |  | Other (income) expense-net
Actuarial losses | 3 |  | (20) |  |  |  |  | Other (income) expense-net
| (2) |  | (31) |  |  |  |  | Total before tax
| 1 |  | (12) |  |  |  |  | Tax
| $ | (1) |  | $ | (43) |  |  |  |  | Net of tax

27

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 11. Shareholders’ Equity (Continued)
The Company’s accounting policy is to release the income tax effects from AOCI when the individual units of account are sold, terminated, or extinguished.
Note 12. Other (Income) Expense – Net
The following table sets forth the items in other (income) expense:

| Three Months Ended |  |
| March 31, |  |
| 2024 |  | 2023 |  |  |  |
| (In millions)
Gains on sale of assets | $ | (2) |  |  | $ | (11) |  |  |  |  |
Other – net | (24) |  |  | (33) |  |  |  |  |
Other (Income) Expense – Net | $ | (26) |  |  | $ | (44) |  |  |  |  |

Gains on sale of assets in the three months ended March 31, 2024 and 2023 consisted of gains on sales of certain assets and disposals of individually insignificant assets in the ordinary course of business.
Other – net in the three months ended March 31, 2024 included the non-service components of net pension benefit income of $5 million, net foreign exchange gains, and net other income. Other – net in the three months ended March 31, 2023 included the non-service components of net pension benefit income of $4 million, net foreign exchange gains, and net other income.
Note 13. Segment Information - Restated
The Company’s operations are organized, managed, and classified into three reportable business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. Each of these segments is organized based upon the nature of products and services offered. The Company’s remaining operations are not reportable segments, as defined by the applicable accounting standard, and are classified as Other Business.
Intersegment sales have been recorded using principles consistent with ASC 606, Revenue from Contracts with Customers. Operating profit for each segment is based on net sales less identifiable operating expenses. Also included in operating profit for each segment is equity in earnings of affiliates based on the equity method of accounting. Specified items and certain corporate items are not allocated to the Company’s individual business segments because operating performance of each business segment is evaluated by management exclusive of these items. Corporate results principally include unallocated corporate expenses, interest cost net of interest income, and revaluation gains and losses on cost method investments and the share of the results of equity investments in early-stage start-up companies.
Restatement of Certain Segment-Specific Historical Financial Information
As described in Note 1 to the Consolidated Financial Statements, the Company has restated its Consolidated Financial Statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023. As a result, the previously reported financial information as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 in this Note 13. Segment Information, has been updated to reflect the restatements.
The following tables set forth the impact of the restatements on intersegment sales and segment operating profit for each of the Company’s three reportable segments for the three months ended March 31, 2024 and 2023.
Intersegment pricing adjustments include restatements related to intersegment sales that were not in accordance with prior disclosures about presenting such sales at amounts approximating market. Intersegment classification adjustments include restatements related to intrasegment sales (resulting from sales within the segment) previously misclassified and reported as intersegment sales (resulting from sales from one segment to another). Intersegment pricing adjustments and Intersegment classification adjustments are included within the Intersegment sales amounts and segment operating profit amounts previously reported by the Company in the Form 10-Q filed with the SEC on April 30, 2024.
28

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 13. Segment Information - Restated (Continued)
In the course of testing new controls implemented as part of the Company’s material weakness remediation plan in the third quarter of 2024, ADM identified additional intrasegment sales previously misclassified and reported as intersegment sales. The Company also identified some intersegment sales that were not accounted for consistently in accordance with revenue recognition and segment reporting standards and should not have been reported as intersegment sales. These amounts are presented in the table below as Additional intersegment classification adjustments. The Company also is correcting certain segment disclosure presentation errors in this Form 10-Q/A. See Note 1 for further information.
Impact of the Restatement on the Ag Services and Oilseeds Segment

| Three Months Ended
| March 31,
(In millions) | 2024 (Restated) | 2023 (Restated)
Intersegment revenues, as originally reported | $ | 609 |  | $ | 1,335 |
Intersegment pricing adjustments | — |  | 1 |
Intersegment classification adjustments | — |  | (595) |
Intersegment revenues, as previously reported | 609 |  | 741 |
Additional intersegment classification adjustments | (183) |  | (211) |
Intersegment revenues, as restated | $ | 426 |  | $ | 530 |
Segment operating profit, as originally reported | $ | 864 |  | $ | 1,210 |
Intersegment pricing adjustments | — |  | 1 |
Segment operating profit, as restated | $ | 864 |  | $ | 1,211 |

Impact of the Restatement on the Carbohydrate Solutions Segment

| Three Months Ended
| March 31,
(In millions) | 2024 (Restated) | 2023 (Restated)
Intersegment revenues, as originally reported | $ | 279 |  | $ | 729 |
Intersegment pricing adjustments | — |  | 6 |
Intersegment classification adjustments | — |  | (230) |
Intersegment revenues, as previously reported | 279 |  | 505 |
Additional intersegment classification adjustments | (71) |  | (235) |
Intersegment revenues, as restated | $ | 208 |  | $ | 270 |
Segment operating profit, as originally reported | $ | 248 |  | $ | 273 |
Intersegment pricing adjustments | — |  | 6 |
Segment operating profit, as restated | $ | 248 |  | $ | 279 |

29

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 13. Segment Information - Restated (Continued)
Impact of the Restatement on the Nutrition Segment

| Three Months Ended
| March 31,
(In millions) | 2024 (Restated) | 2023 (Restated)
Intersegment revenues, as originally reported | $ | 6 |  | $ | 91 |
Intersegment pricing adjustments | — |  | — |
Intersegment classification adjustments | — |  | (55) |
Intersegment revenues, as previously reported | 6 |  | 36 |
Additional intersegment classification adjustments | 7 |  | (24) |
Intersegment revenues, as restated | $ | 13 |  | $ | 12 |
Segment operating profit, as originally reported | $ | 84 |  | $ | 145 |
Intersegment pricing adjustments | — |  | (7) |
Segment operating profit, as restated | $ | 84 |  | $ | 138 |

For more information about the Company’s business segments, refer to Note 17 of “Notes to Consolidated Financial Statements” included in Item 8, “Financial Statements and Supplementary Data” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.
30

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 13. Segment Information - Restated (Continued)

Segment Information for the Three Months ended March 31, 2024 and 2023 |  |  |  |
| Three Months Ended |  |
| March 31, |  |
(In millions) | 2024 |  | 2023 |  |  |  |
Revenues from external customers |  |  |  |  |  |  |
Ag Services and Oilseeds |  |  |  |  |  |  |
Ag Services | $ | 11,197 |  |  | $ | 11,695 |  |  |  |  |
Crushing | 3,327 |  |  | 3,683 |  |  |  |  |
Refined Products and Other | 2,695 |  |  | 3,201 |  |  |  |  |
Total Ag Services and Oilseeds | 17,219 |  |  | 18,579 |  |  |  |  |
Carbohydrate Solutions |  |  |  |  |  |  |
Starches and Sweeteners | 2,156 |  |  | 2,737 |  |  |  |  |
Vantage Corn Processors | 527 |  |  | 800 |  |  |  |  |
Total Carbohydrate Solutions | 2,683 |  |  | 3,537 |  |  |  |  |
Nutrition |  |  |  |  |  |  |
Human Nutrition | 964 |  |  | 936 |  |  |  |  |
Animal Nutrition | 872 |  |  | 917 |  |  |  |  |
Total Nutrition | 1,836 |  |  | 1,853 |  |  |  |  |
Total segment revenues from external customers | 21,738 |  |  | 23,969 |  |  |  |  |
Other Business | 109 |  |  | 103 |  |  |  |  |
Total revenues from external customers | $ | 21,847 |  |  | $ | 24,072 |  |  |  |  |
Intersegment revenues, as restated |  |  |  |  |  |  |
Ag Services and Oilseeds | $ | 426 |  |  | $ | 530 |  |  |  |  |
Carbohydrate Solutions | 208 |  |  | 270 |  |  |  |  |
Nutrition | 13 |  |  | 12 |  |  |  |  |
Total intersegment revenues, as restated | $ | 647 |  |  | $ | 812 |  |  |  |  |
Segment operating profit, as restated |  |  |  |  |  |  |
Ag Services and Oilseeds | $ | 864 |  |  | $ | 1,211 |  |  |  |  |
Carbohydrate Solutions | 248 |  |  | 279 |  |  |  |  |
Nutrition | 84 |  |  | 138 |  |  |  |  |
Total segment operating profit, as restated | 1,196 |  |  | 1,628 |  |  |  |  |
Other Business earnings (loss) | 121 |  |  | 97 |  |  |  |  |
Corporate | (426) |  |  | (322) |  |  |  |  |
Specified items: |  |  |  |  |  |  |
Gains on sale of assets(1) | — |  |  | 1 |  |  |  |  |
Impairment and restructuring charges(2) | (6) |  |  | (7) |  |  |  |  |
Earnings before income taxes | $ | 885 |  |  | $ | 1,397 |  |  |  |  |

(1) Prior quarter gains were related to the sale of certain assets.
(2) Current and prior quarter charges were related to the impairment of certain long-lived assets and restructuring.
31

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 14. Asset Impairment, Exit, and Restructuring Costs
Asset impairment, exit, and restructuring costs in the three months ended March 31, 2024 consisted of impairments related to certain long-lived assets of $3 million and restructuring charges of $3 million, presented as specified items, and restructuring charges in Corporate of $12 million.
Asset impairment, exit, and restructuring costs in the three months ended March 31, 2023 consisted of $3 million of impairments related to certain long-lived assets and $4 million of restructuring charges, presented as specified items.
Note 15. Sale of Accounts Receivable
The Company has an accounts receivable securitization program (the “First Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “First Purchasers”). Under the First Program, certain U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Receivables, LLC (“ADM Receivables”). ADM Receivables transfers certain of the purchased accounts receivable to each of the First Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Receivables receives a cash payment of up to $1.9 billion for the accounts receivable transferred. The First Program terminates on May 17, 2024, unless extended.
The Company also has an accounts receivable securitization program (the “Second Program”) with certain commercial paper conduit purchasers and committed purchasers (collectively, the “Second Purchasers”). Under the Second Program, certain non-U.S.-originated trade accounts receivable are sold to a wholly-owned bankruptcy-remote entity, ADM Ireland Receivables Company (ADM Ireland Receivables). ADM Ireland Receivables transfers certain of the purchased accounts receivable to each of the Second Purchasers together with a security interest in all of its right, title, and interest in the remaining purchased accounts receivable. In exchange, ADM Ireland Receivables receives a cash payment of up to $1.1 billion (€1.0 billion) for the accounts receivables transferred. The Second Program terminates on April 18, 2025, unless extended.
Under the First and Second Programs (collectively, the “Programs”), ADM Receivables and ADM Ireland Receivables use the cash proceeds from the transfer of receivables to the First Purchasers and Second Purchasers (collectively, the “Purchasers”) and other consideration, as applicable, to finance the purchase of receivables from the Company and the ADM subsidiaries originating the receivables. The Company accounts for these transfers as sales. The Company acts as a servicer for the transferred receivables. At March 31, 2024 and December 31, 2023, the Company did not record a servicing asset or liability related to its retained responsibility, based on its assessment of the servicing fee, market values for similar transactions, and its cost of servicing the receivables sold.
As of March 31, 2024 and December 31, 2023, the fair value of trade receivables transferred to the Purchasers under the Programs and derecognized from the Company’s consolidated balance sheets was $2.3 billion and $1.6 billion, respectively. Total receivables sold were $12.3 billion and $15.1 billion for the three months ended March 31, 2024 and 2023, respectively. Cash collections from customers on receivables sold were $11.8 billion and $14.8 billion for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024 and December 31, 2023, receivables pledged as collateral to the Purchasers was $0.7 billion and $1.1 billion, respectively.
Transfers of receivables under the Programs resulted in an expense for the loss on sale of $27 million and $23 million for the three months ended March 31, 2024 and 2023, respectively, which is classified as selling, general, and administrative expenses in the consolidated statements of earnings.
All cash flows under the Programs are classified as operating activities because the cash received from the Purchasers upon both the sale and collection of the receivables is not subject to significant interest rate risk given the short-term nature of the Company’s trade receivables.
32

Archer-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 16. Supplier Finance Programs
ADM has Supplier Payable Programs (“SPP”) with financial institutions which act as its paying agents for payables due to certain of its suppliers. The Company has neither an economic interest in a supplier’s participation in the SPP nor a direct financial relationship with the financial institutions, and has concluded that its obligations to the suppliers, including amounts due and scheduled payment terms, are not impacted by their participation in the SPP. Accordingly, amounts associated with the SPP continue to be classified in trade payables in the Company’s consolidated balance sheet and in operating activities in its consolidated statement of cash flows. The supplier invoices that have been confirmed as valid under the program require payment in full generally within 90 days of the invoice date. As of March 31, 2024 and December 31, 2023, the Company’s outstanding payment obligations that suppliers had elected to sell to the financial institutions were $275 million and $274 million, respectively.
Changes to the outstanding payment obligations are as follows:

| March 31, 2024
| (In millions)
Beginning, January 1, 2024 | $ | 274 |
Obligations confirmed | 257 |
Obligations paid | (256) |
Ending, March 31, 2024 | $ | 275 |

Note 17. Legal Proceedings
The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 10 for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of its business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within Company’s complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice.
Commodities Class Actions
On September 4, 2019, AOT Holding AG (“AOT”) filed a putative class action under the U.S. Commodities Exchange Act in federal district court in Urbana, Illinois, alleging that the Company sought to manipulate the benchmark price used to price and settle ethanol derivatives traded on futures exchanges. On March 16, 2021, AOT filed an amended complaint adding a second named plaintiff Maize Capital Group, LLC (“Maize”). AOT and Maize allege that members of the putative class collectively suffered damages calculated to be between approximately $500 million to over $2.0 billion as a result of the Company’s alleged actions. On July 14, 2020, Green Plains Inc. and its related entities (“GP”) filed a putative class action lawsuit, alleging substantially the same operative facts, in federal court in Nebraska, seeking to represent sellers of ethanol. On July 23, 2020, Midwest Renewable Energy, LLC (“MRE”) filed a putative class action in federal court in Illinois alleging substantially the same operative facts and asserting claims under the Sherman Act. On November 11, 2020, United Wisconsin Grain Producers
33

A rcher-Daniels-Midland Company
Notes to Consolidated Financial Statements (Continued)
(Unaudited)
Note 17. Legal Proceedings (Continued)
LLC (“UWGP”) and five other ethanol producers filed a lawsuit in federal court in Illinois alleging substantially the same facts and asserting claims under the Sherman Act and Illinois, Iowa, and Wisconsin law. The court granted ADM’s motion to dismiss the MRE and UWGP complaints without prejudice on August 9, 2021 and September 28, 2021, respectively. On August 16, 2021, the court granted ADM’s motion to dismiss the GP complaint, dismissing one claim with prejudice and declining jurisdiction over the remaining state law claim. MRE filed an amended complaint on August 30, 2021, which ADM moved to dismiss on September 27, 2021. The court denied ADM’s motion to dismiss on September 26, 2023. UWGP filed an amended complaint on October 19, 2021, which the court dismissed on July 12, 2022. UWGP has appealed the dismissal to the United States Court of Appeals for the Seventh Circuit. On October 26, 2021, GP filed a new complaint in Nebraska federal district court, alleging substantially the same facts and asserting a claim for tortious interference with contractual relations. On March 18, 2022, the Nebraska federal district court granted ADM’s motion to transfer the GP case back to the Central District of Illinois for further proceedings. ADM moved to dismiss the complaint on May 20, 2022 and on December 30, 2022, the court dismissed GP’s complaint with prejudice. GP appealed the dismissal. On January 12, 2024, the appellate court vacated the dismissal and remanded the case to the district court for further proceedings. On March 8, 2024, GP filed an amended complaint. The Company denies liability, and is vigorously defending itself in these actions. As these actions are in pretrial proceedings, the Company is unable at this time to predict the final outcome with any reasonable degree of certainty, but believes the outcome will not have a material adverse effect on its financial condition, results of operations, or cash flows.
Intersegment Sales Investigations
On June 30, 2023, the Company received a voluntary document request from the SEC relating to intersegment sales between the Company’s Nutrition reporting segment and the Company’s Ag Services and Oilseeds and Carbohydrate Solutions reporting segments, and subsequently received an additional document request from the SEC. The Company is cooperating with the SEC. Following the Company’s January 21, 2024 announcement of the Investigation, the Company received document requests from the Department of Justice (“DOJ”) focused primarily on the same subject matter, and the DOJ directed grand jury subpoenas to certain current and former Company employees. The Company is cooperating with the DOJ. The Company is unable to predict the final outcome of these investigations with any reasonable degree of certainty.
Securities Litigation
On January 24, 2024, following the Company’s January 21, 2024 announcement of the investigation relating to intersegment sales, a purported stockholder of the Company filed a putative class action in the U.S. District Court for the Northern District of Illinois against the Company and its Chief Executive Officer, as well as Vikram Luthar and Ray Young. The plaintiff alleges false and misleading statements in the Company’s disclosures and seeks unspecified compensatory and punitive damages. On March 29, 2024 and April 12, 2024, purported stockholders of the Company filed derivative lawsuits in the U.S. District Court for the Northern District of Illinois against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, alleging false and misleading statements in the Company’s proxy statements, breach of fiduciary duty, and corporate waste, among other claims, and seeking unspecified damages. On April 23, 2024, a purported stockholder of the Company filed a derivative lawsuit in the U.S. District Court for the District of Delaware against the Chief Executive Officer, Vikram Luthar, Ray Young, and certain individual ADM Directors, asserting claims for breach of fiduciary duty and contribution and indemnification under the Securities Exchange Act and seeking unspecified damages. The Company is unable to predict the final outcome of these proceedings with any reasonable degree of certainty.
Note 18. Subsequent Event
On April 15, 2024, the Company received a final delivery of 7,325,733 shares at an average share price of $63.065 or $462 million as final settlement of the ASR transaction (see Note 11 for more information).
34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read in conjunction with the accompanying unaudited consolidated financial statements.
Restatement of Previously Issued Consolidated Financial Statements
As described in the Explanatory Note above and in Part I, Item 1, Note 1 to the Consolidated Financial Statements, the Company has restated its Consolidated Financial Statements as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023 contained in this Amendment. As a result, the previously reported financial information as of March 31, 2024 and 2023 and for the quarters ended March 31, 2024 and 2023, in this Item 2. MD&A has been updated to reflect the relevant restatements. See Item 1, Note 1. Basis of Presentation and Restatement of Previously Filed Consolidated Financial Statements, and Note 13. Segment Information, in the Consolidated Financial Statements for additional information related to the restatements, including descriptions of the adjustments and the impacts on the Consolidated Financial Statements. The Company also is correcting certain segment disclosure presentation errors.
Company Overview
ADM is an essential global agricultural supply chain manager and processor; a premier human and animal nutrition provider; a trailblazer in groundbreaking solutions to support healthier living; an industry-leading innovator in replacing petroleum-based products; and a leader in sustainability. The Company is one of the world’s leading producers of ingredients for sustainable nutrition. The Company uses its significant global asset base to originate and transport agricultural commodities, connecting to markets in over 190 countries. The Company also processes corn, oilseeds, and wheat into products for food, animal feed, industrial, and energy uses. The Company also engages in the manufacturing, sale, and distribution of a wide array of ingredients and solutions including plant-based proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, enzymes, botanical extracts, and other specialty food and feed ingredients. The Company uses its global asset network, business acumen, and its relationships with suppliers and customers to efficiently connect the harvest to the home thereby generating returns for its shareholders, principally from margins earned on these activities.
The Company’s operations are organized, managed, and classified into three reportable business segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. Each of these segments is organized based upon the nature of products and services offered. The Company’s remaining operations are not reportable business segments, as defined by the applicable accounting standard, and are classified as Other Business. Financial information with respect to the Company’s reportable business segments is set forth in Note 13 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements”.
ADM’s recent significant portfolio actions and announcements include:
•the acquisitions in January 2024 of Revela Foods, a Wisconsin-based developer and manufacturer of innovative dairy flavor ingredients and solutions and FDL, a UK-based leading developer and producer of premium flavor and functional ingredient systems.
Sustainability is a key driver in ADM’s expanding portfolio of environmentally responsible, plant-derived products. Consumers today increasingly expect their food and drink to come from sustainable ingredients, produced by companies that share their values, and ADM is continually finding new ways to meet those needs through its portfolio actions.
The Company’s strategic transformation is focused on three strategic pillars: Productivity, Innovation, and Culture.
The Productivity pillar includes (1) partnering across various global teams including procurement, supply chain, operations, and commercial to optimize costs and improve production volumes across the enterprise; (2) continued roll out of the 1ADM business transformation program and implementation of improved standardized business processes; and (3) increased use of technology, data analytics, and automation at production facilities, in offices, and with customers to improve efficiencies and customer service.
The Innovation pillar includes expansions and investments in (1) improving the customer experience by leveraging producer relationships and enhancing the use of state-of-the-art digital technology; (2) sustainability-driven innovation, which
35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
encompasses the full range of products, solutions, capabilities, and commitments to serve customers’ needs; and (3) growth initiatives, including organic growth with additional capacity to meet growing market demand and strategic objectives.
The Culture pillar focuses on building capabilities and enabling collaboration, teamwork, and agility from process standardization and digitalization and ADM’s diversity, equity, and inclusion initiatives, which bring new perspectives and expertise to the Company’s decision-making.
ADM plans to support the three pillars with investments in technology, which include expanding digital capabilities and investing further in research and development.
Environmental and Social Responsibility
The Company’s policy to protect forests, biodiversity, and communities includes provisions that promote conservation of water resources and biodiversity in agricultural landscapes, promote solutions to reduce climate change and greenhouse gas emissions, and support agriculture as a means to advance sustainable development by reducing poverty and increasing food security. Additionally, the policy confirms ADM’s commitment to protect human rights defenders, whistleblowers, complainants, and community spokespersons; ADM’s aspiration to cooperate with all parties necessary to enable access to fair and just remediation; and the Company’s non-compliance protocol for suppliers. In 2022, the Company achieved full traceability of its direct and indirect sourcing throughout its soy supply chains in Brazil, Paraguay, and Argentina. ADM is committed to eliminating deforestation from all of the Company’s supply chains by 2025. In 2023, after a strategic investigation of the impact of conversion of native habitats in its key supply chains, the Company announced its commitment to eliminate conversion of native habitats in high risk areas in South America for direct suppliers of all commodities by 2025 and indirect suppliers by 2027, with a 2025 cutoff date (a date after which conversion of primary native vegetation renders a given area or production unit non-compliant) for both direct and indirect suppliers.
The Company’s environmental goals, collectively called “Strive 35” – an ambitious plan to, by 2035, reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 25 percent from a 2019 baseline, reduce Scope 3 emissions by 25% from a 2021 baseline, reduce energy intensity by 15 percent from a 2019 baseline, reduce water intensity by 10 percent from a 2019 baseline, and achieve a 90 percent landfill diversion rate. In 2023, ADM refined two of its Strive 35 commitments to more meaningfully drive progress: ADM aims to reduce its absolute water withdrawal by 10%, from a 2019 baseline, by 2035, and ADM aims to increase its use of low-carbon energy sources to 25% of total energy used by 2035.
Operating Performance Indicators
The Company is exposed to certain risks inherent to an agricultural-based commodity business. These risks are further described in Part I Item 1A, “Risk Factors” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.
The Company’s Ag Services and Oilseeds and Carbohydrate Solutions operations are principally agricultural commodity-based businesses where changes in selling prices move in relationship to changes in prices of the commodity-based agricultural raw materials. As a result, changes in agricultural commodity prices have relatively equal impacts on both revenues and cost of products sold. Therefore, changes in revenues of these businesses do not necessarily correspond to changes in margins or gross profit. Thus, gross margins per volume or metric ton are more meaningful than gross margins as percentage of revenues.
The Nutrition businesses also utilize agricultural commodities (or products derived from agricultural commodities) as raw materials. However, in these operations, agricultural commodity market price changes do not necessarily correlate to changes in cost of products sold. Therefore, changes in revenues of these businesses may correspond to changes in margins or gross profit. Thus, gross margins rates are more meaningful as a performance indicator in these businesses.
The Company has consolidated subsidiaries in more than 70 countries. For the majority of the Company’s subsidiaries located outside the United States, the local currency is the functional currency except for certain significant subsidiaries in Switzerland where Euro is the functional currency, and Brazil and Argentina where U.S. dollar is the functional currency. Revenues and expenses denominated in foreign currencies are translated into U.S. dollars at the weighted average exchange rates for the applicable periods. For the majority of the Company’s business activities in Brazil and Argentina, the functional currency is the U.S. dollar; however, certain transactions, including taxes, occur in local currency and require remeasurement to the functional currency. Changes in revenues are expected to be correlated to changes in expenses reported by the Company caused by
36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
fluctuations in the exchange rates of foreign currencies, primarily the Euro, British pound, Canadian dollar, and Brazilian real, as compared to the U.S. dollar. Effective April 1, 2022, the Company changed the functional currency of its Turkish entities to the U.S. dollar which did not and is not expected to have a material impact on the Company’s consolidated financial statements.
The Company measures its performance using key financial metrics including net earnings, adjusted earnings per share (EPS), gross margins, segment operating profit, total segment operating profit, earnings before interest, taxes, depreciation, and amortization (EBITDA), adjusted EBITDA, return on invested capital, economic value added, and operating cash flows before working capital. Some of these metrics are not defined by accounting principles generally accepted in the United States and should be considered in addition to, and not in lieu of, GAAP financial measures. For more information, see “Non-GAAP Financial Measures” on page 41. The Company’s financial results can vary significantly due to changes in factors such as fluctuations in energy prices, weather conditions, crop plantings, government programs and policies, trade policies, changes in global demand, general global economic conditions, changes in standards of living, global production of similar and competitive crops, and geopolitical developments. Due to the unpredictable nature of these and other factors, the Company undertakes no responsibility for updating any forward-looking information contained within “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Market Factors Influencing Operations or Results in the Three Months Ended March 31, 2024
The Company is subject to a variety of market factors which affect the Company's operating results. In Ag Services and Oilseeds, following two years of very favorable market conditions, several headwinds in the agriculture cycle led to more normalized results throughout the entire value chain. Ag Services experienced slow South American farmer selling, low demand for North American exports, along with low margins in all regions with the move to a carry market. Crushing saw strong run rates, the anticipation of a more normal global supply environment, and new capacity suppressing meal values. In Refined Products and Other, oil values in North America were under pressure due to low carbon intensity feedstocks competing in the renewable diesel market. In Carbohydrate Solutions, demand for starches and sweeteners remained solid with margins remaining steady across the entire portfolio. Industry ethanol stocks remained elevated. Solid export demand for ethanol helped minimize the imbalance between supply and demand. In Nutrition, demand was softer in a few food and beverage product categories. Human Nutrition was impacted by inflation which drove lower demand and impacted volumes in alternative proteins. Demand has started to recover in the food, beverage, and dietary supplement segment. In Animal Nutrition, a soft amino acids market driven by price weakness in North America was partially compensated by a slightly improved market in Europe, Middle East, and Africa (EMEA). The global feed and feed additives market remained challenged on the demand side, with weakness in the Chinese beef and pork business and continued subdued global shrimp prices.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Earnings before income taxes decreased $512 million from $1.4 billion to $885 million. Total segment operating profit (a non-GAAP measure) decreased $432 million from $1.6 billion to $1.2 billion due primarily to lower results in Refined Products and Other, Ag Services, Crushing, Human Nutrition, and Starches and Sweeteners, partially offset by higher results in Wilmar, Vantage Corn Processors, and Animal Nutrition. Total segment operating profit (a non-GAAP measure) excluded asset impairment and restructuring charges totaling $6 million. Excluded from the total segment operating profit (a non-GAAP measure) in the prior-year quarter was a net charge of $6 million consisting of charges totaling $7 million related to asset impairment and restructuring, partially offset by a gain on the sale of certain assets of $1 million. Corporate results in the current quarter were a net charge of $426 million and included restructuring charges of $12 million. Corporate results in the prior-year quarter were a net charge of $322 million and included a mark-to-market gain of $5 million on the conversion option of the exchangeable bonds issued in August 2020.
Income tax expense decreased $59 million to $166 million. The effective tax rate for the quarter ended March 31, 2024 was 18.8% compared to 16.1% for the quarter ended March 31, 2023. The increase in the rate was primarily due to changes in the geographic mix of forecasted pretax earnings and the impact of discrete tax items.
37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Analysis of Statements of Earnings
Processed volumes by product for the quarter are as follows (in metric tons):

| Three Months Ended |
| March 31, |  |
(In thousands) | 2024 |  | 2023 |  | Change
Oilseeds | 9,387 |  |  | 8,627 |  |  | 760 |
Corn | 4,407 |  |  | 4,394 |  |  | 13 |
Total | 13,794 |  |  | 13,021 |  |  | 773 |

The Company generally operates its production facilities, on an overall basis, at or near capacity, adjusting facilities individually, as needed, to react to the current margin environment and seasonal local supply and demand conditions. The overall increase in oilseeds processed volumes was primarily related to improved crush rates in the current quarter compared to lower crush rates in the prior-year quarter resulting from weather related issues and reduced capacity due to the Russian-Ukraine war.
Revenues by segment for the quarter are as follows:

| Three Months Ended |  |
| March 31, |  |
| 2024 |  | 2023 |  | Change
| (In millions)
Ag Services and Oilseeds |  |  |  |  |
Ag Services | $ | 11,197 |  |  | $ | 11,695 |  |  | $ | (498) |
Crushing | 3,327 |  |  | 3,683 |  |  | (356) |
Refined Products and Other | 2,695 |  |  | 3,201 |  |  | (506) |
Total Ag Services and Oilseeds | 17,219 |  |  | 18,579 |  |  | (1,360) |
Carbohydrate Solutions |  |  |  |  |
Starches and Sweeteners | 2,156 |  |  | 2,737 |  |  | (581) |
Vantage Corn Processors | 527 |  |  | 800 |  |  | (273) |
Total Carbohydrate Solutions | 2,683 |  |  | 3,537 |  |  | (854) |
Nutrition |  |  |  |  |
Human Nutrition | 964 |  |  | 936 |  |  | 28 |
Animal Nutrition | 872 |  |  | 917 |  |  | (45) |
Total Nutrition | 1,836 |  |  | 1,853 |  |  | (17) |
Total Segment Revenues | 21,738 |  |  | 23,969 |  |  | (2,231) |
Other Business | 109 |  |  | 103 |  |  | 6 |
Total Revenues | $ | 21,847 |  |  | $ | 24,072 |  |  | $ | (2,225) |

Revenues and cost of products sold in a commodity merchandising and processing business are significantly correlated to the underlying commodity prices and volumes. During periods of significant changes in commodity prices, the underlying performance of the Company is better evaluated by looking at margins because both revenues and cost of products sold, particularly in Ag Services and Oilseeds, generally have a relatively equal impact from market price changes, which generally result in an insignificant impact to gross profit.
38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Revenues decreased $2.2 billion to $21.8 billion due to lower sales prices ($5.0 billion), partially offset by higher sales volumes ($2.8 billion). Lower sales prices of oils, corn, soybeans, and meal and lower sales volumes of alcohol, rapeseed, and farming materials, were partially offset by higher sales volumes of corn, soybeans, wheat, and meal. Ag Services and Oilseeds revenues decreased 7% to $17.2 billion due to lower sales prices ($4.3 billion), partially offset by higher sales volumes ($3.0 billion). Carbohydrate Solutions revenues decreased 24% to $2.7 billion due to lower sales prices ($0.7 billion) and lower sales volumes ($0.2 billion). Nutrition revenues of $1.8 billion was comparable to the prior-year quarter.
Cost of products sold decreased $1.8 billion to $20.2 billion due principally to lower average commodity costs. Manufacturing expenses decreased $86 million to $1.8 billion due principally to lower energy costs, partially offset by higher salaries and benefit costs and commercial service fees.
Foreign currency translation increased revenues by $64 million and cost of products sold by $64 million.
Gross profit decreased $0.4 billion or 20% to $1.7 billion. Lower results in Ag Services and Oilseeds ($363 million), Starches and Sweeteners ($58 million), and Human Nutrition ($48 million) were partially offset by higher results in Vantage Corn Processors ($18 million), Animal Nutrition ($17 million), and Other ($17 million). These factors are explained in the segment operating profit discussion on page 4 0.
Selling, general, and administrative expenses increased $70 million to $951 million due primarily to higher legal and professional fees, increased amortization of intangibles, and higher salaries and benefit costs.
Asset impairment, exit, and restructuring costs increased $11 million to $18 million. Charges in the current quarter consisted of $3 million of impairments related to certain long-lived assets and $3 million of restructuring, presented as specified items, and restructuring of $12 million in Corporate. Charges in the prior-year quarter consisted of $3 million of impairments related to certain long-lived assets and $4 million of restructuring, presented as specified items.
Equity in earnings of unconsolidated affiliates increased $38 million to $212 million due primarily to higher earnings from the Company’s investment in Wilmar.
Interest and investment income decreased $11 million to $123 million due primarily to a valuation loss related to an investment in alternative protein and precision fermentation, partially offset by higher interest income driven by higher interest rates.
Interest expense increased $19 million to $166 million due primarily to increased short-term rates on customer deposit balances in ADM Investor Services. Interest expense in the prior-year quarter also included a mark-to-market gain adjustment of $5 million related to the conversion option of the exchangeable bonds issued in August 2020.
Other income-net decreased $18 million to $26 million. Income in the current quarter included gains on disposals of individually insignificant assets in the ordinary course of business, the non-service components of net pension benefit income, net foreign exchange gains, and net other income. Income in the prior-year quarter included gains on disposals of individually insignificant assets in the ordinary course of business, the non-service components of net pension benefit income, net foreign exchange gains, and net other income.
39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Total segment operating profit (a non-GAAP measure) is reconciled to earnings before income taxes, the most directly comparable GAAP measure, for the quarters ended March 31, 2024 and 2023 as follows:

| Three Months Ended |  |
| March 31, |  |
| 2024 |  | 2023 |  | Change
| (In millions)
Earnings before income taxes | $ | 885 |  |  | $ | 1,397 |  |  | $ | (512) |
Other Business (earnings) loss | (121) |  |  | $ | (97) |  |  | (24) |
Corporate | 426 |  |  | 322 |  |  | 104 |
Specified Items: |  |  |  |  |
Gains on sale of assets | — |  |  | (1) |  |  | 1 |
Impairment and restructuring charges | 6 |  |  | 7 |  |  | (1) |
Total Segment Operating Profit | $ | 1,196 |  |  | $ | 1,628 |  |  | $ | (432) |
Segment Operating Profit |  |  |  |  |
Ag Services and Oilseeds |  |  |  |  |
Ag Services | $ | 232 |  |  | $ | 348 |  |  | $ | (116) |
Crushing | 313 |  |  | 427 |  |  | (114) |
Refined Products and Other | 170 |  |  | 327 |  |  | (157) |
Wilmar | 149 |  |  | 109 |  |  | 40 |
Total Ag Services and Oilseeds | $ | 864 |  |  | $ | 1,211 |  |  | $ | (347) |
Carbohydrate Solutions |  |  |  |  |
Starches and Sweeteners | $ | 261 |  |  | $ | 313 |  |  | $ | (52) |
Vantage Corn Processors | (13) |  |  | (34) |  |  | 21 |
Total Carbohydrate Solutions | $ | 248 |  |  | $ | 279 |  |  | $ | (31) |
Nutrition |  |  |  |  |
Human Nutrition | $ | 76 |  |  | $ | 138 |  |  | $ | (62) |
Animal Nutrition | 8 |  |  | — |  |  | 8 |
Total Nutrition | $ | 84 |  |  | $ | 138 |  |  | $ | (54) |

Ag Services and Oilseeds segment operating profit decreased 29%. Ag Services results were lower than the first quarter of 2023 due to the stabilization of trade flows leading to lower global trade and risk management results. Crushing results were lower than the prior-year quarter as increased imports of used cooking oil and the anticipation of large South American supplies negatively impacted North American soy crush margins. Significant positive mark-to-market timing impacts that contributed to the prior-year quarter results also drove lower results in the current quarter. Refined Products and Other results were lower than the prior-year quarter as the increased imports of used cooking oil negatively impacted refining margins in North America. Negative mark-to-market timing impacts affected current quarter results versus positive impacts in the prior-year quarter. Equity earnings from Wilmar were higher versus the first quarter of 2023.
Carbohydrate Solutions segment operating profit decreased 11%. Starches and Sweeteners results were lower year-over-year as strong starches and sweeteners margins were offset by lower domestic ethanol margins due to strong industry production and elevated stocks, as well as moderating margins in the EMEA region. Vantage Corn Processors results improved year-over-year as strong demand for sustainably certified exports of ethanol supported volumes and margins.
Nutrition segment operating profit decreased 39%. Human Nutrition results were lower than the first quarter of 2023 as impacts related to unplanned downtime at Decatur East and a normalizing texturants market negatively impacted margins.
40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Animal Nutrition results were higher compared to the same quarter last year as cost optimization efforts and lower input costs bolstered margins.
Other Business operating profit increased $24 million. Captive insurance results were higher due to higher program premiums and lower claims. ADM Investor Services results improved on higher net interest income.
Corporate results for the quarter are as follows:

| Three Months Ended |  |  |  |
| March 31, |  |  |  |
| 2024 |  | 2023 |  | Change |  |
| (In millions) |  |
Interest expense-net | $ | (110) |  |  | $ | (103) |  |  | $ | (7) |  |  |
Unallocated corporate costs | (304) |  |  | (248) |  |  | (56) |  |  |
Gain on debt conversion option | — |  |  | 5 |  |  | (5) |  |  |
Restructuring charges | (12) |  |  | — |  |  | (12) |  |  |
Other income | — |  |  | 24 |  |  | (24) |  |  |
Total Corporate | $ | (426) |  |  | $ | (322) |  |  | $ | (104) |  |  |

Corporate results were a net charge of $426 million in the current quarter compared to a net charge of $322 million in the prior-year quarter. Interest expense-net increased $7 million due primarily to lower capitalized interest. Unallocated corporate costs increased $56 million due primarily to increases in legal and professional fees, global technology spend, incentive compensation accruals, and financing costs. Gain on debt conversion option in the prior-year quarter was related to the mark-to-market adjustment of the conversion option of the exchangeable bonds issued in August 2020. Other income in the current quarter includes foreign exchange gains of $15 million and the non-service components of net pension benefit income of $5 million offset by an investment revaluation loss of $18 million. Other income in the prior-year quarter included the non-service components of net pension benefit income of $4 million and foreign exchange gains of $22 million.
Non-GAAP Financial Measures
The Company uses adjusted net earnings, adjusted earnings per share (EPS), adjusted EBITDA, and total segment operating profit, non-GAAP financial measures as defined by the SEC, to evaluate the Company’s financial performance. These performance measures are not defined by accounting principles generally accepted in the United States and should be considered in addition to, and not in lieu of, GAAP financial measures.
Adjusted net earnings is defined as net earnings adjusted for the effects on net earnings of specified items. Adjusted EPS is defined as diluted EPS adjusted for the effects on reported diluted EPS of specified items. EBITDA is defined as earnings
before interest on borrowings, taxes, and depreciation and amortization. Adjusted EBITDA is defined as earnings before interest, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Total segment operating profit is defined as ADM’s consolidated earnings before income taxes, adjusted for Other business, Corporate, and specified items.
Management believes that adjusted net earnings, adjusted EPS, adjusted EBITDA, and total segment operating profit are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. Adjusted net earnings, adjusted EPS, adjusted EBITDA, and total segment operating profit are not intended to replace or be an alternative to net earnings, diluted EPS, net earnings, and earnings before income taxes, respectively, the most directly comparable amounts reported under GAAP. The table on page 4 0 provides a reconciliation of total segment operating profit to earnings before income taxes for the three months ended March 31, 2024 and 2023.
In this Amendment, the Company is revising its reconciliation and calculation of total segment operating profit. The revised reconciliation in Note 13. Segment Information presents a subtotal for total segment operating profit that is equal to the sum of the segment operating profit reported for each of the Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments.
41

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Amounts for other business and specified items, which previously were reflected in the calculation of total segment operating profit, are now reflected as reconciling items, similar to Corporate, between total segment operating profit and earnings before income taxes.
The table below provides a reconciliation of net earnings to adjusted net earnings and diluted EPS to adjusted EPS for the three months ended March 31, 2024 and 2023.

| Three months ended March 31,
| 2024 |  | 2023
| In millions |  | Per share |  | In millions |  | Per share
Average number of shares outstanding - diluted | 514 |  |  |  |  | 551 |  |  |
Net earnings and reported EPS (fully diluted) | $ | 729 |  |  | $ | 1.42 |  |  | $ | 1,170 |  |  | $ | 2.12 |
Adjustments: |  |  |  |  |  |  |
Gains on sale of assets - net of tax of $0 million (1) | — |  |  | — |  |  | (1) |  |  | — |
Gain on debt conversion option - net of tax of $0 million (1) | — |  |  | — |  |  | (5) |  |  | (0.01) |
Impairment and restructuring charges - net of tax of $0 million in 2024 and $2 million in 2023 (1) | 18 |  |  | 0.03 |  |  | 5 |  |  | 0.01 |
Certain discrete tax adjustments | 3 |  |  | 0.01 |  |  | (18) |  |  | (0.03) |
Total adjustments | 21 |  |  | 0.04 |  |  | (19) |  |  | (0.03) |
Adjusted net earnings and adjusted EPS | $ | 750 |  |  | $ | 1.46 |  |  | $ | 1,151 |  |  | $ | 2.09 |

(1) Tax effected using the U.S. and other applicable tax rates.
The tables below provide a reconciliation of net earnings to adjusted EBITDA for the three months ended March 31, 2024 and 2023.

| Three months ended |  |
| March 31, |  |
(In millions) | 2024 |  | 2023 |  | Change
Net earnings | $ | 729 |  |  | $ | 1,170 |  |  | $ | (441) |
Net earnings (losses) attributable to noncontrolling interests | (10) |  |  | 2 |  |  | (12) |
Income tax expense | 166 |  |  | 225 |  |  | (59) |
Interest expense | 115 |  |  | 100 |  |  | 15 |
Depreciation and amortization | 280 |  |  | 259 |  |  | 21 |
EBITDA | 1,280 |  |  | 1,756 |  |  | (476) |
(Gain) loss on sales of assets and businesses | — |  |  | (1) |  |  | 1 |
Impairment and restructuring charges | 18 |  |  | 7 |  |  | 11 |
Adjusted EBITDA | $ | 1,298 |  |  | $ | 1,762 |  |  | $ | (464) |

42

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
Liquidity and Capital Resources
A Company objective is to have sufficient liquidity, balance sheet strength, and financial flexibility to fund the operating and capital requirements of a capital-intensive agricultural commodity-based business. The Company depends on access to credit markets, which can be impacted by its credit rating and factors outside of ADM’s control, to fund its working capital needs and capital expenditures. The primary source of funds to finance ADM’s operations, capital expenditures, and advancement of its growth strategy is cash generated by operations and lines of credit, including a commercial paper borrowing facility and accounts receivable securitization programs. In addition, the Company believes it has access to funds from public and private equity and debt capital markets in both U.S. and international markets.
Cash provided by operating activities was $0.7 billion for the three months ended March 31, 2024 compared to a use of $1.6 billion for the same period last year. Working capital changes decreased cash by $0.2 billion for the three months ended March 31, 2024 compared to a decrease of $2.9 billion for the same period last year. Segregated investments increased $0.2 billion due to increased trading activity in the Company’s futures commission and brokerage business. Trade receivables decreased $0.1 billion due to lower revenues. Inventories decreased $0.3 billion due to lower inventory prices and volumes. Trade payables decreased $0.7 billion primarily due to lower payables related to grain purchases. Brokerage payables increased approximately $0.3 billion due to increased trading activity in the Company’s futures commission and brokerage business.
Cash used in investing activities was $1.2 billion for the three months ended March 31, 2024 compared to $0.3 billion for the same period last year. Capital expenditures for the three months ended March 31, 2024 of $0.3 billion was comparable to the same period last year. Net assets of businesses acquired in the three months ended March 31, 2024 were $0.9 billion compared to none in the same period last year.
Cash used in financing activities was $2 million for the three months ended March 31, 2024 compared to cash provided of $0.6 billion for the same period last year. Long-term debt payments were immaterial for the three months ended March 31, 2024 compared to $2 million for the same period last year. Net borrowings on short-term credit agreements for the three months ended March 31, 2024 were $1.6 billion compared to $1.3 billion for the same period last year. Share repurchases for the three months ended March 31, 2024 were $1.3 billion compared to $0.4 billion for the same period last year. Dividends were $0.3 billion for the three months ended March 31, 2024 compared to $0.2 billion for the same period last year.
At March 31, 2024, the Company had $0.8 billion of cash and cash equivalents and a current ratio, defined as current assets divided by current liabilities, of 1.5 to 1. Included in working capital was $6.7 billion of readily marketable commodity inventories. At March 31, 2024, the Company’s capital resources included shareholders’ equity of $23.2 billion and lines of credit, including the accounts receivable securitization programs described below, totaling $12.8 billion, of which $8.8 billion was unused. The Company’s ratio of long-term debt to total capital (the sum of long-term debt of $8.2 billion and shareholders’ equity of $23.2 billion in 2024 and the sum of long-term debt of $8.3 billion and shareholders’ equity of $24.1 billion in 2023) was 26% and 25% at March 31, 2024 and December 31, 2023, respectively. The Company uses this ratio as a measure of the Company’s long-term indebtedness and an indicator of financial flexibility. The Company’s ratio of net debt (the sum of short-term debt of $1.7 billion, current maturities of long-term debt of $1 million, and long-term debt of $8.2 billion less the sum of cash and cash equivalents of $0.8 billion and short-term marketable securities of none in 2024 and the sum of short-term debt of $0.1 billion, current maturities of long-term debt of $1 million, and long-term debt of $8.3 billion less the sum of cash and cash equivalents of $1.4 billion and short-term marketable securities of none in 2023) to capital (the sum of net debt of $9.2 billion and shareholders’ equity of $23.2 billion in 2024 and the sum of net debt of $7.0 billion and shareholders' equity of $24.1 billion in 2023) was 28% and 22% at March 31, 2024 and December 31, 2023, respectively. Of the Company’s total lines of credit, $5.0 billion supported the combined U.S. and European commercial paper borrowing programs, against which there was $0.9 billion of commercial paper outstanding at March 31, 2024.
As of March 31, 2024, the Company had $0.8 billion of cash and cash equivalents, $0.7 billion of which was cash held by foreign subsidiaries whose undistributed earnings are considered indefinitely reinvested. Based on the Company’s historical ability to generate sufficient cash flows from its U.S. operations and unused and available U.S. credit capacity of $5.2 billion, the Company has asserted that these funds are indefinitely reinvested outside the U.S.
The Company has accounts receivable securitization programs (the “Programs”) with certain commercial paper conduit purchasers and committed purchasers. The Programs provide the Company with up to $3.0 billion in funding against accounts receivable transferred into the Programs and expands the Company’s access to liquidity through efficient use of its balance sheet assets (see Note 15 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements” for
43

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (Continued)
more information and disclosures on the Programs). As of March 31, 2024, the Company had $0.7 billion unused capacity of its facility under the Programs.
As of March 31, 2024, the Company has total available liquidity of $9.6 billion comprised of cash and cash equivalents and unused lines of credit with a well-diversified group of primarily investment-grade institutions.
For the three months ended March 31, 2024, the Company spent approximately $0.3 billion in capital expenditures, $0.3 billion in dividends, and $1.3 billion in share repurchases. The Company has a stock repurchase program. On March 12, 2024, the Company entered into an ASR Agreement with Merrill Lynch International, an affiliate of BofA Securities, Inc., to repurchase $1.0 billion of ADM common stock as part of ADM’s existing share repurchase program to repurchase up to 200 million shares through December 31, 2024. On March 28, 2024, the Company received an interim delivery of 8,880,986 shares at an average share price of $60.596 or $538 million. Under the program, the Company had 38.5 million shares remaining as of March 31, 2024 that may be repurchased until December 31, 2024. On April 15, 2024, the Company received a final delivery of 7,325,733 shares as final settlement of the ASR transaction (see Notes 11 and 18 of “Notes to Consolidated Financial Statements” included in Item 1 herein, “Financial Statements” for more information). As of the final settlement date, the Company had 31.2 million shares remaining that may be repurchased under the program until December 31, 2024.
In 2024, the Company expects total capital expenditures of approximately $1.3 billion and additional cash outlays of approximately $1.0 billion in dividends and up to $2.3 billion in share repurchases, subject to other strategic uses of capital and the evolution of operating cash flows and the working capital position throughout the year.
Contractual Obligations and Commercial Commitments
The Company’s purchase obligations as of March 31, 2024 and December 31, 2023 were $12.2 billion and $14.0 billion, respectively. The decrease is primarily related to lower energy commitments and obligations to purchase agricultural commodity inventories at lower prices. As of March 31, 2024, the Company expects to make payments related to purchase obligations of $11.6 billion within the next twelve months. There were no other material changes in the Company’s contractual obligations during the quarter ended March 31, 2024.
Off Balance Sheet Arrangements
There were no material changes in the Company’s off balance sheet arrangements during the quarter ended March 31, 2024.
Critical Accounting Policies and Estimates
There were no material changes in the Company’s critical accounting policies and estimates during the quarter ended March 31, 2024. For a description of the Company’s critical accounting policies, estimates, and assumptions used in the preparation of the Company’s financial statements, see Part II, Item 7 and Note 1 of “Notes to Consolidated Financial Statements” included in Part II, Item 8, of the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The market risk inherent in the Company’s market risk sensitive instruments and positions is the potential loss arising from adverse changes in: commodity market prices as they relate to the Company’s net commodity position, foreign currency exchange rates, and interest rates. Significant changes in market risk sensitive instruments and positions for the quarter ended March 31, 2024 are described below. There were no material changes during the period in the Company’s potential loss arising from changes in foreign currency exchange rates and interest rates.
For detailed information regarding the Company’s market risk sensitive instruments and positions, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” included in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.
44

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK (Continued)
Commodities
The availability and prices of agricultural commodities are subject to wide fluctuations due to factors such as changes in weather conditions, crop disease, plantings, government programs and policies, competition, changes in global demand, changes in customer preferences and standards of living, and global production of similar and competitive crops.
The fair value of the Company’s commodity position is a summation of the fair values calculated for each commodity by valuing all of the commodity positions at quoted market prices for the period, where available, or utilizing a close proxy. The Company has established metrics to monitor the amount of market risk exposure, which consist of volumetric limits and value-at-risk (VaR) limits. VaR measures the potential loss, at a 95% confidence level, that could be incurred over a one-year period. Volumetric limits are monitored daily and VaR calculations and sensitivity analysis are monitored weekly.
In addition to measuring the hypothetical loss resulting from an adverse two standard deviation move in market prices (assuming no correlations) over a one-year period using VaR, sensitivity analysis is performed measuring the potential loss in fair value resulting from a hypothetical 10% adverse change in market prices. The highest, lowest, and average weekly position together with the market risk from a hypothetical 10% adverse price change is as follows:

|  | Three months ended |  | Year ended
|  | March 31, 2024 |  | December 31, 2023
Long/(Short) (In millions) |  | Fair Value |  | Market Risk |  | Fair Value |  | Market Risk
Highest position |  | $ | (265) |  |  | $ | (27) |  |  | $ | 498 |  |  | $ | 50 |
Lowest position |  | 6 |  |  | 1 |  |  | (6) |  |  | (1) |
Average position |  | (56) |  |  | (6) |  |  | 125 |  |  | 13 |

The change in fair value of the average position was due to the overall decrease in average quantities, partially offset by the increase in prices of certain commodities.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
At the time of the filing of this Amendment, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of March 31, 2024. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer, concluded the Company’s disclosure controls and procedures were not effective as of March 31, 2024, due to the material weakness described below.
Internal Control Over Financial Reporting
As disclosed in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023, during the fourth quarter of 2023, in connection with the Investigation, the Company identified a material weakness in its internal control over financial reporting related to the Company’s accounting practices and procedures for segment disclosures. The material weakness resulted from inadequate controls that allowed for certain intersegment sales to be reported at amounts that were not in accordance with ASC 606, Revenue from Contracts with Customers. Specifically, the Company did not have adequate controls in place around measurement of certain intersegment sales between the Company’s reporting segments. In addition, appropriate controls were not in place for the reporting of intersegment sales and for the application of disclosure requirements within ASC 280, Segment Reporting. The absence of adequate controls with respect to the reporting of intersegment sales impacted the completeness and accuracy of the Company’s segment disclosures and review controls over projected financial information utilized in goodwill and other long-lived asset impairment tests.
Remediation Plan
The Company is implementing enhancements to its internal controls to remediate the identified material weakness in its internal control over financial reporting related to the Company’s accounting practices and procedures for intersegment sales and to enhance the reliability of its financial statements with respect to the pricing and reporting of such sales. Specifically, the
45

ITEM 4. CONTROLS AND PROCEDURES (Continued)
Company is: (i) enhancing the Company’s accounting policies with respect to the measurement of intersegment sales; (ii) improving and documenting the Company’s pricing guidelines for intersegment sales; (iii) enhancing the design and documentation of the execution of pricing and measurement controls, including as to the completeness and accuracy of the reporting for intersegment sales disclosure purposes and projected financial information used in impairment analyses; and (iv) increasing training for relevant personnel on the measurement of and application of relevant accounting guidance to intersegment sales and segment disclosures.
While the Company believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether the steps the Company is taking will remediate the material weakness in internal control over financial reporting until a sustained period of time has passed to allow management to test the design and operational effectiveness of the new and enhanced controls.
Changes in Internal Control Over Financial Reporting
The Company is implementing a new enterprise resource planning (ERP) system on a worldwide basis, which is expected to occur in phases over the next several years. The Company did not have any further deployments of the ERP system during the quarter ended March 31, 2024.
Except for the material weakness described above and the related remediation measures that are being implemented, there have been no changes in internal control over financial reporting during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
During the quarter ended March 31, 2024, the Company completed the acquisitions of Revela, FDL, and PT. As a result of the acquisitions, the Company is in the process of reviewing the internal control structures of these businesses and, if necessary, will make appropriate changes as the Company incorporates its controls and procedures into the acquired businesses.
46

PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The Company is routinely involved in a number of actual or threatened legal actions, including those involving alleged personal injuries, employment law, product liability, intellectual property, environmental issues, alleged tax liability (see Note 10, Income Taxes of “Notes to Consolidated Financial Statements” included in Part I, Item 1 herein, “Financial Statements,” for information on income tax matters), and class actions. The Company also routinely receives inquiries from regulators and other government authorities relating to various aspects of our business, and at any given time, the Company has matters at various stages of resolution. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. In some actions, claimants seek damages, as well as other relief including injunctive relief, that could require significant expenditures or result in lost revenues. In accordance with applicable accounting standards, the Company records a liability in its consolidated financial statements for material loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a material loss contingency is reasonably possible but not known or probable, and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the consolidated financial statements. When determining the estimated loss or range of loss, significant judgment is required to estimate the amount and timing of a loss to be recorded. Estimates of probable losses resulting from litigation and governmental proceedings involving the Company are inherently difficult to predict, particularly when the matters are in early procedural stages, with incomplete facts or legal discovery; involve unsubstantiated or indeterminate claims for damages; potentially involve penalties, fines, disgorgement, or punitive damages; or could result in a change in business practice. See Note 17, Legal Proceedings of “Notes to Consolidated Financial Statements” included in Part I, Item 1 herein, “Financial Statements,” for information on the Company’s legal proceedings which is incorporated herein by reference.
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2023.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities

Period |  | Total Number of Shares Purchased(1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of a Publicly Announced Program(2) |  | Number of Shares Remaining to be Purchased Under the Program(2)
January 1, 2024 to |  |  |  |  |  |  |  |
January 31, 2024 |  | 4,654,264 |  |  | $ | 70.260 |  |  | 4,653,786 |  |  | 47,379,648 |
February 1, 2024 to |  |  |  |  |  |  |  |
February 29, 2024 |  | 412,208 |  |  | 52.976 |  |  | — |  |  | 47,379,648 |
March 1, 2024 to |  |  |  |  |  |  |  |
March 31, 2024 |  | 9,325,919 |  |  | 60.387 |  |  | 8,880,986 |  |  | 38,498,662 |
Total |  | 14,392,391 |  |  | $ | 63.368 |  |  | 13,534,772 |  |  | 38,498,662 |

(1)Total shares purchased represent those shares purchased in the open market as part of the Company’s publicly announced share repurchase program described below, shares received as payment for the exercise price of stock option exercises, and shares received as payment for the withholding taxes on vested restricted stock awards. During the three-month period ended March 31, 2024, there were 857,619 shares received as payments for the withholding taxes on vested restricted stock awards.
(2)On November 5, 2014, the Company’s Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to 100,000,000 shares of the Company’s common stock during the period commencing January 1, 2015 and ending December 31, 2019. On August 7, 2019, the Company’s Board of Directors approved the
47

ITEM 4. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (Continued)
extension of the stock repurchase program through December 31, 2024 and the repurchase of up to an additional 100,000,000 shares under the extended program.
ITEM 5. OTHER INFORMATION
None of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction, or written plan for the purchase or sale of ADM’s securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2024.
ITEM 6. EXHIBITS

(3)(i) |  | Composite Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3(i) to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2001).
(3)(ii) |  | Bylaws, as amended through November 2, 2022 (incorporated by reference to Exhibit 3(ii) to the Company’s Annual Report on Form 10-K filed on February 14, 2023).
(10.1) |  | Form of Performance Share Unit Award Agreement under the Company’s 2020 Incentive Compensation Plan. (incorporated by reference to Exhibit (10.1) to the Company's Quarterly Report on Form 10-Q filed on April 30, 2024)
(10.2) |  | Form of Restricted Stock Unit Award Agreement under the Company’s 2020 Incentive Compensation Plan.(incorporated by reference to Exhibit (10.2) to the Company's Quarterly Report on Form 10-Q filed on April 30, 2024)
(31.1) |  | Certification of Principal Executive Officer pursuant to Rule 13a–14(a) and Rule 15d–14(a) of the Securities Exchange Act of 1934, as amended.
(31.2) |  | Certification of Principal Financial Officer pursuant to Rule 13a–14(a) and Rule 15d–14(a) of the Securities Exchange Act of 1934, as amended.
(32.1) |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(32.2) |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
(101) |  | Inline XBRL file set for the consolidated financial statements and accompanying notes in Part I, Item 1, “Financial Statements” and for the information under Part II, Item 5, “Other Information” of this Quarterly Report on Form 10-Q.
(104) |  | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL file set.

48

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | ARCHER-DANIELS-MIDLAND COMPANY
Dated: | November 18, 2024 | /s/ M. Patolawala
|  | M. Patolawala
|  | Chief Financial Officer
|  | (Principal Financial Officer and Duly Authorized Officer)

49